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For many years, the insides of bacterial cells were thought to be unstructured, with key 
cell components ‘floating around’ in the cytosol. However, around 60 years ago, small 
protein shells were discovered in a type of bacteria that get their energy from 
photosynthesis and were named carboxysomes. Carboxysomes were found to contain 
two enzymes that take carbon dioxide and ‘fix’ it into useful sugars: ribulose-1,5-
bisphosphate carboxylase/oxygenase (known as RuBisCO) and carbonic 
anhydrase (CA). Alone, RuBisCO is a very poor enzyme, in that the conversion of 
CO2 to sugar is very slow. By localising the RuBisCO and carbonic anhydrase, which 
makes carbon dioxide from bicarbonate, together in the protein shell, the efficiency of 
RuBisCO is much increased. 
Since the discovery of the carboxysomes, other types of protein shells containing 
enzymes have been found in a wide range of different bacteria, and these have been 
named bacterial microcompartments (BMCs). BMCs look similar to carboxysomes, 
but they work in the opposite direction: they break down sugars to provide the cells 
with energy. However, these reactions produce toxic chemicals, so the BMCs also 
protect the cell from these by keeping them inside their shell. One particular BMC is 
the fucose/rhamnose microcompartment in the soil bacterium Clostridium 
phytofermentans, which takes the sugars fucose and rhamnose and breaks them down 
into molecules used for the energy within the cell. One important enzyme in this 
pathway is called an aldehyde dehydrogenase; it uses two different molecules (NAD+ 
and Coenzyme A {CoA}) to turn an aldehyde (a component of fucose/rhamnose 
breakdown) into an acyl-CoA, which can be used to generate energy for the cell. 
Although the general structure of the aldehyde dehydrogenase had been solved by X-
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ray crystallography, up until now it was unclear how this enzyme works. The first part 
of this project shows the crystal structure of the aldehyde dehydrogenase with the 
NAD+ and CoA cofactors in the active site; the latter for the first time. Along with 
data generated from an enzyme activity experiment, shows how this enzyme works, 
which is an exciting development in the field of BMC study. 
The second part of the project is focused on synthetic biology. A common definition 
of synthetic biology is ‘designing and constructing biological modules, biological 
systems and biological machines, or re-design of existing biological systems for useful 
purposes. Shell proteins of BMCs are described as ‘modular’, because they are made 
of three different protein types, two proteins that form hexagonal arrangements and a 
pentagon that can be put together in many different combinations to form the ‘football-
shaped’ microcompartment. As BMCs are beneficial to the cell because they protect 
it from toxic molecules, it is possible to use the principals of synthetic biology to 
design and make synthetic BMCs, which can then be used to target different useful 
molecules inside them. This part of the project looks at the synthetic biology of BMCs 
from three different angles: 
1. Can we use a specifically designed toolkit of biological parts to 
generate synthetic microcompartments using the protein shells from two 
different types of bacteria? 
2. Can we take the protein sequence that directs the enzymes to the BMC, 
from the aldehyde dehydrogenase described in the earlier part of the project 
and use it to see if it affects the level of expression of a particular fluorescent 
protein? 
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3. Finally, can we take a particular type of shell protein called EutM, from 
four different bacteria, and overexpress it in E. coli to see what happens to the 
shell of the BMC 






Bacterial microcompartments (BMCs) are proteinaceous metabolic compartments 
found in a wide range of bacteria, whose function it is to encapsulate pathways for the 
breakdown of various carbon sources, whilst retaining toxic and volatile intermediates 
formed from substrate breakdown. Examples of these metabolic processes are the 1,2-
propanediol-breakdown pathway in Salmonella enterica (Pdu microcompartment), as 
well as the ethanolamine breakdown pathway in Clostridium difficile (Eut 
microcompartment). Some of the major challenges to exploiting BMCs as a tool in 
biotechnology are understanding how enzymes are targeted to microcompartments, as 
well as being able to engineer the protein shell of BMCs to make synthetic 
microcompartments that allow specific enzyme pathways to be targeted to their 
interior. Finally, the metabolic burden imposed by the production of large protein 
complexes requires a detailed knowledge of how the expression of these systems are 
controlled. 
This project explores the structure and biochemistry of an essential BMC pathway 
enzyme, the acylating propionaldehyde dehydrogenase. With crystal structures of the 
enzyme with the cofactors in the cofactor binding site and biochemical data presented 
to confirm the enzyme’s substrate. The project also focuses on the creation of synthetic 
biology tools to enable BMC engineering with a modular library of BMC shell protein 
parts; forward engineered ribosome binding sites (RBS) fused to BMC aldehyde 
dehydrogenase localisation sequences. The parts for this library were taken from the 
BMC loci found in Clostridium phytofermentans and Salmonella enterica. Using a 
synthetic biology toolkit will allow the rapid prototyping of BMC constructs for use 
in metabolic engineering. The shell protein parts were used to generate a number of 
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transcriptional units, to assess the effect of overexpression of individual BMC shell 
components on the morphology of BMCs and the effect these had on their host chassis. 
Different strength forward engineered RBS and localisation constructs have been 
designed to assess the possibility of controlling the levels of heterologous proteins 
targeted to the interior of microcompartment shell to allow metabolic engineering of 
encapsulated pathways. Along with looking at overexpression of a single shell protein, 
to assess viability of BMCs as scaffold-like structures, recombinant BMCs can be 






     Bacterial microcompartments 
 
Bacteria have been used for many years as model organisms to study many different 
facets of biology. Most of the knowledge gleaned from basic molecular processes such 
as transcription and translation comes from initial studies into bacterial molecular 
biology. However, the bacterial cell was first thought to be unstructured and 
uncompartmentalised, unlike eukaryotic cells with their complex internal organisation 
(Gitai, 2005). This view was challenged around 50 years ago when bacterial 
microcompartments (BMCs) were first observed in the chemoautotrophic bacterium 
Halothiobacillus neapolitanus (Shively et al., 1973), by thin-section electron 
micrographs of the bacterium. They found that the compartments contained ribulose 
1,5-bisphosphate, which is involved in carbon dioxide fixation, and proposed that the 
structures be named carboxysomes. 
A BMC consists of a pseudo-icosahedral shaped protein shell, which is selectively 
permeable to substrates and products formed from either anabolic or catabolic 
reactions, and contains enzymes to metabolise these reactions, shown in Figure 1.1 
(Kerfeld et al., 2010, 2018). This form of compartmentalisation has arisen as a way to 
enhance metabolic flux through multi-step pathways, and may also increase enzyme 
stability (Jakobson et al., 2017). The separation of the encapsulated enzymes and the 
bacterial cytosol is also thought to protect the cell from toxic volatile intermediates 
(Chen and Silver, 2012). There are two main types of BMCs, α- and β- carboxysomes 
and metabolosomes. Although both are composed of a protein shell with encapsulated 
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enzymes, they differ in function, assembly and enzyme targeting. Their similarities 
and differences are described in the following sections. 
 
 
Figure 1.1. Transmission electron micrographs of BMCs 
a) The cyanobacterium Synechocystis PCC6803 with a single carboxysome (P. Shih 
and C.A. Kerfeld,  unpublished data). (b) Pdu and (c) Eut BMCs in Salmonella  
(courtesy of J. Shively and the late H. Aldrich).  (d) BMCs in Clostridium kluyveri  
grown on ethanol and acetate (courtesy of R. Lurz). (e) BMCs in Clostridium 
phytofermentans grown on fucose (courtesy of J. Blanchard). (f) Putative BMCs in 
Pirellula staleyi (courtesy of M. Rohde). Taken from Kerfeld et al. 2010. An example 





1.1.1 α and β–Carboxysomes 
 
Despite the functional diversity of BMCs, they tend to be conserved in their basic 
architecture. The first microcompartment to be characterized, the carboxysome, is 
found in many chemoautotrophic bacteria and all cyanobacteria (Kerfeld and 
Melnicki, 2016). It constitutes the main part of the cyanobacterial Carbon 
Concentrating Mechanism (CCM) (Badger and Price, 1992; Price et al., 2008) a 
system that involves the active uptake of inorganic carbon into the cell and its 
intracellular accumulation, primarily as HCO3−. HCO3− diffuses through the 
carboxysome shell; within the lumen, an encapsulated carbonic anhydrase (CA) 





Metabolosomes are a subgroup of BMCs that differ from carboxysomes in their 
function, encapsulating pathways for catabolic reactions, as opposed to the anabolic 
carbon fixation pathway found in carboxysomes. The function of these 
microcompartments is to sequester enzymes to enhance the enclosed metabolic 
pathway, and to protect the bacterial cell from the toxic and volatile intermediates 
produced during metabolic reactions (Brinsmade et al., 2005; Penrod and Roth, 2006; 
Sampson and Bobik, 2008). They tend to fall under three main BMC types; 
propanediol utilisation microcompartments (PDU) (Bobik et al., 1999) ethanolamine 
utilisation (EUT) (Kofoid et al., 1999) and ethanol utilisation (ETU) (Heldt et al., 
2009). However, advances in bioinformatics techniques have allowed for the 
identification of many different types of BMCs among 19 out of the 29 established 
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bacterial phyla (Axen et al., 2014). This introduction will focus on the Pdu, Eut and 
Etu BMCs, describing both their metabolic pathways and their microcompartment 
shell formation, as well as recent advances in synthetic microcompartment formation 
and enzyme targeting. 
 
1.1.2.1 Propanediol utilisation (PDU) micrcompartments 
The first Pdu locus to be discovered was by Bobik et al. in 1999. They described the 
pdu operon of Salmonella enterica serovar Typhimurium LT2 as having genes 
associated with coenzyme B12 – dependent catabolism of 1,2 – propanediol. It was 
shown there were also five genes associated with carboxysome-like proteins, which 
make up the shells of the Pdu microcompartment, and these polyhedral-like shells were 
only formed during bacterial growth on propanediol (Bobik et al., 1999). Since then, 
Pdu BMCs have been shown in a range of different bacteria, including Citrobacter 
freundii (Parsons et al., 2008), Clostridium phytofermentans (Petit et al., 2013) and 
Lactobacillus reuteri (Sriramulu et al., 2008). The production of 1,2 – propanediol 
from the breakdown of the plant cell wall sugars fucose and rhamnose, is an ideal 
carbon and energy source for enteric bacteria, where access to plant matter is widely 
available (Kerfeld et al., 2010). In this particular pathway, encapsulation of enzymes 
and substrates away from the bacterial cytosol is thought to be advantageous to the 
cell, as the propionaldehyde intermediate is highly reactive and is thought to have an 





1.1.2.2 Ethanolamine utilisation (Eut) microcompartments 
Ethanolamine is an important carbon and energy source for mammals, produced from 
the degradation of the gastrointestinal membrane component phosphatidyl- 
ethanolamine (Stojiljkovic et al., 1995). In a similar way to the pdu operon, the eut 
operon genes encode homologues of carboxysome shell proteins (Stojiljkovic et al., 
1995). The Eut microcompartments are most widely studied in both Salmonella 
enterica and Escherichia coli (Jakobson et al., 2017; Kofoid et al., 1999; Penrod and 
Roth, 2006; Pitts et al., 2012; Roof and Roth, 1992), two bacteria common to the 
mammalian gut. Again, one of the intermediates of this breakdown pathway, this time 
acetaldehyde rather than propionaldehyde, is highly reactive and therefore necessary 
to be contained within the microcompartment (Cheng et al., 2008; Kerfeld et al., 2010). 
 
1.1.2.3 Ethanol utilisation (Etu) microcompartment 
A study by Heldt et al. in 2009 suggested that there were microcompartment shell 
proteins (EtuA and EtuB) encoded on the genome of Clostridium kluyveri, that share 
60% sequence identity with the carboxysome protein CsoS1A. This potential operon 
also contains genes for two ethanol dehydrogenases and three aldehyde 
dehydrogenases, as well as the two shell protein genes (Heldt et al., 2009). Clostridium 
kluyveri is unique among the clostridia as it grows strictly anaerobically on ethanol 
and acetate as energy sources (Seedorf et al., 2008), meaning that encapsulation of 





1.2      BMC metabolic pathways 
 
One of the main differences between carboxysomes and metabolosomes is in their 
carbon source breakdown pathways (Figure 1.2). Carboxysome-containing autotrophs 
are found in environments where dissolved inorganic carbon (DIC) levels are below 
the necessary threshold to support efficient RubisCO-mediated CO2 fixation. The 
microcompartment works by increasing the concentration of DIC in proximity to the 
active site of RubisCO, which helps to overcome the poor affinity of the enzyme for 
its substrate. The BMC shell works to lessen the amount of DIC that can escape from 
the microcompartment (Kerfeld et al., 2010; Rae et al., 2013). 
 
1.2.1 α-carboxysome and β-carboxysome metabolism 
 
α- and β- carboxysomes are both responsible for encapsulating RuBisCO and CA, and 
have a similar enzyme pathway although they have two different forms of the 
RuBisCO molecule, type 1A (α) and 1B(β)(Rae et al., 2013). In this pathway, the 
carbonic anhydrase turns over bicarbonate to CO2 in a cyclical reaction. RuBisCO then 
uses CO2 to turnover Ribulose 1,5-bisphosphate into 3-phosphoglycerate, which 





Figure 1.2. Schematic representation of simplified metabolic pathways within BMCs. 
A) Fucose/rhamnose Pdu microcompartment, B) α- carboxysome, C) Eut BMC and 
D) Etu BMC. Figure adapted from (Kerfeld et al., 2010). Key enzymes and 
metabolites are highlighted for clarity,  with each giving a general overview of the 
microcompartment enzymes required for each pathway, and show the end products 
that are released from the BMC back into the bacterial cell. Aldehyde dehydrogenase 
is abbreviated to Adh and alcohol dehydrogenase is Alc 
  
1.2.2 1,2 – propanediol metabolism 
 
A pathway for 1,2-PD degradation has previously been described; it is also one of the 
most well-characterized microcompartment pathways (Petit et al., 2013) (Figure 1.3). 
It starts with the conversion of 1,2-PD to propionaldehyde by coenzyme B12- 
dependent diol dehydratase. Then the aldehyde is converted to 1-propanol and 
propionic acid by propanol dehydrogenase and coenzyme A-dependent 
propionaldehyde dehydrogenase. A phosphotransacylase, and propionate kinase then 
act to produce intermediates for substrate-level phosphorylation. This process provides 
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ATP, reducing equivalents in the form of NADH, and potentially a three- carbon 
intermediate (propionyl-coenzyme A) that is degraded to pyruvate and succinate via 
the methylcitrate pathway. The NADH generated from this is likely to be part of a 
closed NAD+/NADH cofactor pool, and explains the need for both aldehyde 
dehydrogenases and alcohol dehydrogenases within the BMC shell (Bobik et al., 1999; 
Petit et al., 2013). 
Clostridium phytofermentans, a mesophilic anaerobe isolated from forest soil is 
another bacterium that has BMCs for breakdown of biological matter such as cellulose, 
into energy for the cell (Methé et al., 2002). The genome of this organism is unique in 
that it contains three loci encoding BMCs, one of which is for the breakdown of fucose 
and rhamnose (Figure 1.3). Comparative genome analysis suggests that this particular 





Figure 1.3. Genes associated with the fucose/rhamnose breakdown pathway in 
Clostridium phytofermentans 
A) A representation of the locus of the fucose/rhamnose (Fuc) BMC. Genes involved 
in the pathway described below are shown in green, shell proteins shown in blue, 
aldehyde dehydrogenase in purple and the transcriptional regulator is shown in 
purple. B) A model of the C. phytofermentans fucose and rhamnose fermentation 
pathways, adapted from Petit et  al.  (2013).  Enzymes shown in green are 
encapsulated within the BMC. 
  
1.2.3 Ethanolamine metabolism 
 
The pathway of ethanolamine breakdown consists of the deamination of the two- 
carbon compound ethanolamine into acetaldehyde, an intermediate that is thought to 
be toxic to the cell and therefore the primary reason for encapsulating this process 
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(Pitts et al., 2012). The acetaldehyde is further broken down into acetyl-phosphate, 
which is then utilized in substrate-level phosphorylation (Chowdhury et al., 2014). 
EutE is the aldehyde dehydrogenase and EutG the alcohol dehydrogenase, with the 
NAD+/NADH turnover cycling between these two particular enzymes (Huseby and 
Roth, 2013). This cofactor pool is important biochemically, as it describes another 
need for the encapsulation of these enzymes (Stojiljkovic et al., 1995). 
 
1.2.4 Ethanol metabolism 
 
The most well studied example of the ethanol metabolism microcompartment is from 
Clostridium kluyveri. This bacterium is able to grow solely on ethanol and acetate as 
carbon sources, and uses an ethanol dehydrogenase to convert ethanol to acetaldehyde 
with NAD+ as a cofactor. The acetaldehyde is then converted to acetyl- CoA, via an 
aldehyde dehydrogenase, again using NAD+ and Co-enzyme A as cofactors. The 
resulting acetyl-CoA then leaves the bacterial microcompartment, and enters the 
Kreb’s cycle, where end products butyrate and acetic acid are generated (Seedorf et 
al., 2008). 
  
1.3      Glycyl-radical enzymes 
 
Glycyl-radical enzyme (GRE) microcompartments are the most abundant type of 
BMC, but are only recently beginning to be experimentally characterised. The first 
glycyl-radical enzyme microcompartment to be characterized, was the 
fucose/rhamnose BMC from Clostridium phytofermentans (Petit et al., 2013), with the 
main enzyme of this pathway reported to be a 1,2-propandiol dehydratase. There are 
5 distinct microcompartments within GRE microcompartments that are assumed to be 
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different in their function (Kerfeld et al., 2018), with the differences coming down to 
whether the enzyme is B12-independent or B12-dependent. The GRM5 described here 
is B12-independent, whereas the Pdu operon in Salmonella enterica relies on vitamin 
B12 for the catabolism of 1,2-propanediol to propionaldehyde (Bobik et al., 1999; 
Jeter, 1990). 
To detoxify the aldehydes produced from GREs, either from B12-dependent or B12- 
independent pathways, an aldehyde dehydrogenase is needed to resolve the acyl- 
coenzyme A intermediate and produce an NADH molecule from the turnover of NAD+ 
(Jorda et al., 2013). 
This project will focus in detail on the biochemistry and structure of the aldehyde 
dehydrogenase from the microcompartment described in Petit et al. (2013) above 
  
1.4      Overview of BMC protein shell structure 
 
The protein shells of bacterial microcompartments are composed of three different 
protein domains, BMC-H, BMC-P and BMC-T. A mix of these three proteins types is 
able to form the canonical pseudo-icosahdral BMC shell, with the BMC-H and BMC-
T proteins making the flat-faces of the icosahedron, with the vertices formed by 
pentameric proteins (Pitts et al., 2012). Most BMC shell proteins adopt structures in 
which the hexamer has a bowl-shaped inversion on one side, specifically the side on 
which both the N- and C- termini reside in the typical BMC domain and the BMC 
domain adopts an α/β-fold with a central four-stranded antiparallel β-sheet flanked by 
small α-helices (Kerfeld et al., 2005). 
BMC-H forms a 6-fold symmetrical hexamer and is the most common type of domain 
in the microcompartment (Figure 1.4). BMC-T is the next most abundant type and its 
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monomer consists of a tandem repeat of the BMC domain, which comes together to 
form pseudo-hexameric trimers. Finally, the least abundant, and most structurally 
divergent BMC protein is the BMC-P, which forms a pentameric structure that is 
thought to assemble the icosahedral vertices of the microcompartment (Lassila et al., 
2014) (Figure 1.5). The paper from Lassila et al. (2014), also suggests that the BMC- 
H protein shells are likely to only form flat sheets without the presence of the BMC- 
T protein, meaning that BMC-T gives curvature to the microcompartment, and allows 
the BMC-P protein somewhere to bind. 
 
  
Figure 1.4. A cartoon representation of the crystal structure of the EutM shell protein from 
Clostridium difficile 
A)A cartoon representation of the EutM monomer in the C. difficile ethanolamine 
util izationmicrocompartment,  with secondary structure elements coloured and 
labelled from N- to C- termini. B) Hexameric arrangement of EutM, showing the  
asymmetric unit contents in blue and symmetry related molecules in grey, with the 
two-fold symmetry axis generating this arrangement shown as a grey circle. Small 





Figure 1.5. A representation of the three main types of bacterial microcompartment shell proteins 
and their pfam domains 
BMC-H is a hexameric domain, BMC-T is a tandem hexamer domain and BMC-P is 
a pentameric domain. These three shell protein types make up all metabolosomes 
studied to date, with BMC-H being the most abundant type, followed by BMC-T and 
finally BMC-P. BMC- T has two subtypes, based on oligomeric status, either single 
or double layers (Kerfeld et al., 2018).  
 
1.4.1 Hexameric domains (BMC-H) 
 
The most abundant type of bacterial microcompartment shell protein is the BMC-H 
hexameric domain. It contains 6 single Pfam00936 domains, assembled into a cyclic 
homohexamer, with both a convex and concave side (Kerfeld et al., 2005). An example 
of a BMC-H protein from the Clostridium phytofermentans ethanolamine BMC is 
shown in Figure 1.4. BMC-H proteins form the faces of the bacterial 
microcompartment shells, with the concave side of the homohexamer facing out into 







1.4.2 Tandem hexameric domains (BMC-T) 
 
BMC-T proteins are made up of a tandem fusion of two Pfam00936 domains and as 
such form trimers that resemble the BMC-H hexamers. The two subtypes of BMC-T 
are BMC-Ts (single) and BMC-Td (double), the former is a single trimer and the latter 
has two trimers dimerizing across their concave faces (Kerfeld et al., 2018) (Figure 
1.4). 
 
1.4.3 Pentameric domains (BMC-P) 
 
BMC-P proteins (Pfam03319) are pentameric in shape, and form the vertices of the 
microcompartment shell. They are much less abundant than the BMC-H and –T 
proteins, however they are thought to be essential to provide the barrier for a 
completely closed microcompartment shell (Cai et al., 2009). 
 
1.4.4 Microcompartment shell assembly 
 
Despite α- and β- carboxysomes being similar in terms of their enzyme pathways, with 
both utilizing RuBisCO and CA for CO2 fixation, it has been shown that the β- 
carboxysomes are much more closely related to metabolosomes than they are to α- 
carboxysomes (Cameron et al., 2013). This is apparent most in the assembly of the β- 
carboxysome and metabolosome microcompartment shells, with the β-carboxysome 
core assembling first followed by encapsulation of the shell. As metabolosome core 
enzymes tend to aggregate and have putative localization sequences that are thought 
to interact with the shell (Fan et al., 2010), it is likely that their encapsulation pathway 
is also core-first. However, in α-carboxysomes the protein shell and core proteins are 
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likely to be assembled at the same time (Iancu et al., 2010). In the context of synthetic 
biology, the difference in assembly methods between carboxysome and metabolosome 
types could have a big impact in terms of building synthetic microcompartment 
systems, particularly with regards to targeting enzymes to the microcompartment shell. 
 
1.5      Bacterial microcompartment enzyme-shell targeting 
 
Although it is likely that there is a difference how key pathway enzymes are targeted 
to the microcompartment, one particular study has shown that an N-terminal signal 
peptide is vital for the encapsulation of the PduP (propionaldehyde dehydrogenase) 
from the Pdu microcompartment in Salmonella enterica (Fan et al., 2010) with another 
study showing the same effect in Citrobacter freundii (Lawrence et al., 2014). These 
enzymes were localized via a short, N-terminal aldehyde dehydrogenase localization 
sequence, 18 amino acids in length. In the paper by Fan et al., (2010), they identify the 
targeting site for the enzyme localization sequence, which in this instance is the H81, 
V84 and L88 of the PduA shell protein C-terminus. 
Many studies so far have looked at bacterial microcompartments with a view to 
engineering them to make synthetic compartments that can be utilized in biofuel 
production, including creating empty carboxysomes (Menon et al., 2008) 
overexpression of BMC shell proteins from a Pdu microcompartment (Parsons et al., 
2008), formation of nanotubes using a BMC-H protein (Noël et al., 2016) and 
engineering of BMC shell proteins to introduce a new function (Aussignargues et al., 
2016). However, these tend to use classical cloning methods, which are costly and time 
consuming, particularly if large numbers of constructs need to be produced. Advances 
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in synthetic biology cloning techniques mean that BMCs have the potential to become 
extremely useful tools for a wide range of applications. 
  
1.6     BMCs as tools for synthetic biology 
 
Interest in the study of BMCs is growing as research moves towards synthetic biology 
and the use of standardized parts as platforms for biotechnology and metabolic 
engineering. By studying how the microcompartment shells are formed and how the 
enzymes used in the breakdown pathways are recruited to the BMC, it should be 
possible to synthesize empty microcompartments, into which biologically useful 
enzyme pathways can be added. These synthetic microcompartments could then be 
used to optimize efficiency of pathways used in the synthesis of fine drugs and 
chemicals, as well as to help reduce toxicity and the release of volatile intermediates 
into host cells. The examples in the following sections highlight the cutting-edge work 
being carried out into microcompartment bioengineering. 
 
1.6.1 Bacterial microcompartments in bioengineering 
 
An example of using bioengineering to enhance the modularity of BMCs was shown 
by Parsons et al. (2008). This study took the 21 gene Pdu operon from Citrobacter 
freundii and showed that it was fully functional within E. coli cells, for both 
microcompartment formation and metabolic activity (Parsons et al., 2008). 
Carboxysomes have also been highly engineered, with a study showing that the alpha-
carboxysome of the chemoautotroph Halothiobacillus neapolitanus has been 
expressed in E. coli, with the resulting particles showing CO2 fixing activity (Bonacci 
et al., 2012). Another interesting study, by (Quin et al., 2016), shows that it is possible 
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to take the localization sequences from two different Eut microcompartment enzymes, 
EutC and EutE and use them to target GFP to a specific microcompartment shell 
protein, EutS, which ultimately allows them to be encapsulated. These relatively recent 
examples show that all microcompartments are potentially heterologous, which has 
interesting implications for future rational design of synthetic microcompartments 
 
1.7     Golden Gate cloning and Type II restriction enzymes 
 
To utilize the inherent modular properties of BMCs and make them into a useful toolkit 
system would be expensive and time-consuming using standard cloning methods. The 
recent advances in Golden-Gate cloning, using Type II restriction endonucleases 
means that it is possible to build a system of BMC ‘parts’ quickly and effectively. 
Techniques such as ‘gap repair cloning’ were first used as an approach to synthetic 
biology and high-throughput cloning. In a yeast-cloning system, this involves 
amplifying the ORF with ORF-specific primers that have flanking sequences 
homologous to the ends of a linearized cloning vector (Marsischky and LaBaer, 2004). 
A similar system was developed for E. coli as prokaryotic system, using a λ Red/ 
recET- mediated recombination (Datsenko and Wanner, 2000; Marsischky and 
LaBaer, 2004). Downsides to this cloning method include the fact that it is not possible 
to easily transfer clones between different vectors and the PCR primers necessary for 
this technique are fairly long and therefore prone to synthesis errors (Marsischky and 
LaBaer, 2004). This is an example of one of many techniques that has tried to improve 
upon standard cloning methods, without satisfying all of the needs of fully robust 
system. Ideally, synthetic biological parts would be easy to transfer between different 
vector systems, quick to clone (< one day), and inexpensive to make, with a scar-less 
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insertion into the acceptor vector. The next section describes some recent exciting 
techniques to improve upon current bioengineering efforts. 
 
1.7.1 Type II restriction endonucleases 
 
Type II restriction endonucleases such as BsaI work on the principal of DNA cleavage 
outside of their recognition site, resulting in 5’ or 3’ DNA overhangs that can be a 
specified nucleotide sequence. This gives 256 possible different overhang sequences 
that can be designed with multiple fragment assembly in mind (Engler et al., 2008). 
Two defined DNA ends can be designed to be flanked by a type II restriction site, so 
that the enzyme recognition sequence is removed, but a user-specified overhang 
sequence remains (Figure 1.6). This property allows cloning to be performed using a 
one-step restriction-ligation. This strategy was shown to result in the conversion of 
more than half of all input plasmids present into the desired recombinant product in 
just a 30 minute restriction-ligation reaction (Engler et al., 2008). 
 
1.7.2 CIDAR MoClo: Modular assembly standard 
 
The strategy to assemble synthetic BMCs needs to be time and cost-effective, as well 
as being able to generate large DNA libraries in a rational way. The Modular cloning, 
or MoClo system (Iverson et al., 2015; Weber et al., 2011) is a multipart, one-pot 
digestion system that allows users to generate specific overhangs for each ‘part’, such 
as the RBS or a CDS and insert them in to a specific acceptor vector system. As the 
system uses type II restriction endonucleases, once the enzyme has cut outside of the 
recognition site, the recognition site disappears. This allows subsequent cycles of 
digestion and ligation for maximal plasmid insertion. The MoClo system works on a 
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plasmid ‘hierarchy’ – the Level 0 plasmids are used to put user-defined ‘parts’ into the 
system. The next level builds the Level 0 parts into transcriptional units, using Level 
1 vectors with kanamycin resistance genes, rather than ampicillin (Level 0 and Level 
2). The differences in antibiotic resistance between the levels mean that it is easy to 
establish which constructs have been produced. The Level 2 plasmids join together 
two separate transcriptional units, which goes some way to alleviating the problem 
that a maximum of only six parts can be cloned into a Level 1 vector. 
The MoClo system has a library of often-used genetic parts, including promoters, 
RBSs, reporter proteins (GFP, YFP), and terminators, as well as a 3 part vector system 
to insert DNA parts in to build transcriptional units (Figure 1.6 and Table 1.1). The 
basic parts to build the toolkit were taken from either the BioBrick registry 
(http://partsregistry.org), or Addgene, a useful parts repository. The BioBrick registry 
is developed as part of the International Genetically Engineered Machine (iGEM) 
competition, that involves students worldwide building biologically useful 
standardised parts, as part of the competition. This registry is a valuable source of 
Anderson promoters, reporter proteins and chromoproteins, along with plant and 
Bacillus subtilis chassis and parts for metal sensing and binding (Casini et al., 2014; 
Osbourn et al., 2012; Sarrion-Perdigones et al., 2011). 
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Figure 1.6 SBOL generated figures to show the assembly of the MoClo transcriptional units. 
Colours refer to a MoClo specified sequence, shown in Table 1.1 with the promoter 
(top left), RBS (top right), ORF (bottom left)  and terminator (bottom right) Level 0 
plasmid being mixed together in a one-pot assembly, using a Type II restriction 
endonuclease and BsaI l igase to cut and insert the fragments into a transcriptional  
vector (Iverson et al.,  2015; Werner et al. , 2012).  
 
Part type 5’ overhang 3’ overhang 
Promoter A - GGAG B - AGTA 
RBS B - TACT C - CATT 
Reporter gene C - AATG D - ACCT 
Terminator D - AGGT E - AAGC 
Acceptor plasmid A - CCTC E - GCTT 
Table 1.1 5’ and 3’ toolkit defined overhangs of the MoClo system 
Colours of overhangs co-ordinate to SBOL images in Figure 1.6. 
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1.8     Aims and objectives 
 
• Chapters 2 and 3: The first aim is to characterise the aldehyde dehydrogenase 
from the Clostridium phytofermentans fucose/rhamnose Pdu microcompartment. This 
thesis will describe the Michaelis-Menten kinetics of the enzyme and find its 
biologically relevant aldehyde substrate, using NAD+ turnover assays. Control active 
site variants will also be assayed. As well as this, the first crystallographic structure of 
an acylating aldehyde dehydrogenase with CoA in the cofactor binding site will be 
shown, with this data helping to propose a mechanism of action for the aldehyde 
dehydrogenase. Knowledge gained from this work will help further the understanding 
of a complicated enzyme mechanism, for future studies into overall BMC biology. 
• Chapter 4: As part of the CIDAR MoClo toolkit, a wide range of constitutive 
and controllable promoters, high, medium and low strength RBSs, a number of 
fluorescent reporter genes and terminators with suitable overhangs for different levels 
of the system are available. The toolkit parts will be used to construct a shell protein 
library, to develop various transcriptional units with different numbers of shell proteins 
from different bacterial species, with a view to expressing and visualizing these 
synthetic microcompartment shells with TEM. The second objective is to design RBS 
and localisation sequence constructs with the localisation sequences from Salmonella 
and C. phytofermentans Pdu microcompartments. The rationale behind this is to find 
out if a fixed protein part downstream of the different strength RBSs will lead to 
differing expression levels of fluorescent reporter, or if there is a particular strength 
RBS that will be optimal for production of the reporter. This can hopefully be used to 
test targeting a specific amount of protein to a microcompartment. The final objective 
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is to look at EutM shell proteins across different species with our collaborators in the 
Schmidt-Dannert lab. The EutM proteins have been shown to have differing charge 
states across their surfaces, particularly around the pores that are responsible for the 
influx and efflux of metabolites from BMCs. It would be interesting to get a three-
dimensional view of the EutM shell protein, either by crystallising the protein or 
looking at protein overexpression with thin-section electron microscopy. This data 
would help elucidate the role of BMC shell proteins as possible scaffolds for novel 
enzyme pathway targeting. 
• Chapter 5: This chapter is a discussion of the results from chapters 2-4. 
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2 Expression and purification of acylating aldehyde 
dehydrogenase enzymes from Clostridium phytofermentans 




In the C. phytofermentans genome, there are three putative aldehyde dehydrogenase 
enzymes associated with Bacterial Microcompartment loci: Cphy1178, Cphy1428 and 
Cphy2642 (Petit et al., 2013, 2015). The aldehyde dehydrogenase family is split into 
acylating and non-acylating variants. The mechanism of the acylating aldehyde 
dehydrogenases is as follows: 
Aldehyde + NAD+ + Coenzyme A ↔ Acyl-CoA + NADH + H+ 
Aldehyde dehydrogenases play an important role in the sugar breakdown pathways of 
many bacterial microcompartments, mentioned in detail in Chapter 1. The homologue 
of the putative enzymes mentioned above is the probable aldehyde dehydrogenase 
from Listeria monocytogenes (PDBID: 3K9D), although the mechanism of action for 
this enzyme is not shown. Two ligands are annotated in the crystal structure, a chloride 
ion and a glycerol molecule, however neither the NAD+ or CoA cofactors are shown. 
The aim of this section is to recombinantly express and purify soluble Cphy1178, 
Cphy1428 and Cphy2642 proteins, to allow further enzyme characterisation. 
  
2.1.1 Overexpression of recombinant Cphy1178, Cphy1428
 and Cphy2642 
 
Work to previously characterise Cphy1178, Cphy1428 and Cphy2642 was carried out 
by Thiau Fu Ang (Undergraduate honours student, Marles-Wright lab). The full-
length, wild-type forms of these enzymes were found to be unstable, so a truncated 
version of Cphy1178, Cphy1428 and Cphy2642 was designed, without the proposed 
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N-terminal tag (shown in the protein sequence alignment in Figure 3.1). A small scale-
expression test was carried out with the truncated proteins, and they were found to 
show a suitable amount of protein for large-scale purification. E. coli cells, 
transformed with plasmids containing genes for Cphy1178(20-462), Cphy1428 and 
Cphy2642, were cultured as described in Materials and Methods, then lysed with SDS-
loading buffer and subjected to 12% w/v SDS-PAGE. The nomenclature of the 
truncated versions of the proteins are as follows: Cphy1178_20/Cphy1178(20-462), 
Cphy1428, Cphy2642. 
     
Figure 2.2 Expression tests of BMC-associated aldehyde dehydrogenases from 
C. phytofermentans produced recombinantly in E. coli BL21 (DE3) cells.  
Cphy1178_20, Cphy1428 and Cphy2642. T0 and T3 refer to 1 ml samples taken at 
the point of  induction and three hours after induction with 1mM IPTG, respectively;  
then analysed by 12% SDS-PAGE. The red arrow indicates where the bands for the 
required enzymes are expected based up the calculated molecular weight (approx. 











Cphy1178_20 47.5 6.41 16,960 
Cphy1428 52.0 6.08 18,910 
Cphy2642 50.1 8.22 14,440 
Table 2.1 Calculated parameters of the three aldehyde dehydrogenase enzymes 
Parameters were calculated using Kyoto Encyclopaedia of Genes and Genomes 
(KEGG) for the protein sequence, and ProtParam (ExPASy) software. 
 
The protein expression tests indicated that all three proteins were overexpressed to 
high levels and were therefore amenable to large-scale (1 litre) expression and 
purification. However, as an exploratory expression test, the proteins were not tested 
for solubility at this stage, just overall expression in the cells. 
  
2.1.2 Purification of recombinant aldehyde dehydrogenases by anion 
exchange and size-exclusion chromatography 
 
Once the appropriate expression conditions of induction had been established (1 mM 
IPTG after cell growth to an OD600 0.6) for Cphy1178_20, Cphy1428 and Cphy2642, 
the enzymes were purified from 1 litre of LB culture of E. coli. The cells were 
harvested, lysed by sonication and the soluble fraction clarified by centrifugation 
followed by filtration. 
The proteins were subject to anion exchange using a Q-sepharose column (full 
protocol and buffer details in Methods chapter), with the chromatograms and SDS- 
PAGE gels shown in Figures 2.3, 2.5 and 2.7 for Cphy1178, Cphy1428 and Cphy2642 
respectively. A further purification step was necessary to get a purer protein product. 
Samples taken and pooled from the Q-sepharose column were concentrated for further 
purification on a size-exclusion chromatography column. Work undertaken by Didi 
He in the Marles-Wright lab shows the calibration curve for the HiLoad 16/600 
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Superdex 200pg Size Exclusion Chromatography column (see Appendix). Pooled 
samples were concentrated to 2 ml and injected on to a HiLoad 16/600 Superdex 200pg 
Size Exclusion Chromatography column. This stage of purification was successful for 
constructs Cphy1178_20 and Cphy1428 (Figures 2.4 and 2.6), so fractions of the 
correct size were pooled and their concentration measured by nanodrop, using the MW 
and extinction coefficient values from Table 2.1. However no protein was observed 
after Size Exclusion Chromatography of Cphy2642. Protein purified from size-
exclusion purification was deemed to be clean enough to use for the aldehyde 
dehydrogenase NAD+ turnover assays described later in this chapter. 
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Figure 2.3 Anion exchange purification of recombinant Cphy1178. 
Purification from a 12 ml Q-sepharose column. X1 corresponds to the flow-through, 
which contained a small percentage of unbound protein. Bound proteins were eluted 
by a l inear gradient over 20 column volumes from 0–1 M NaCl as fractions from A1 
– H5. Fractions from A) were analysed by 15% SDS-PAGE, in which fractions A1 – 
D12 showed a band of the appropriate size (red arrow). Fractions were pooled from 







Figure 2.4 Size-exclusion chromatography purification of recombinant Cphy1178. 
Purification from a 120 ml HiLoad 16/600 Superdex column. Fractions A3 – E8 were 
analysed by 15% w/v SDS-PAGE gel (B). Protein of the correct size was observed 
in fractions B3-B5. 
  





Figure 2.5 Anion exchange purification of recombinant Cphy1428. 
Purification from a 12 ml Q-sepharose column. Fraction X1 corresponds to the 
flowthrough. Fractions were eluted by a l inear gradient over 20 column volumes from 
0–1 M NaCl as fractions from A2 – H7. Fractions from A) were analysed by 15% 
SDS-PAGE, in which only fractions B10-D10 showed a band of the appropriate size 






Figure 2.6 Size-exclusion chromatography purification of recombinant Cphy1428. 
Purification from a 120 ml HiLoad 16/600 Superdex column. Fractions A3 – E8 were 






Figure 2.7 Anion exchange purification of recombinant Cphy2642. 
Purification from a 12 ml Q-sepharose column. Fraction X1 corresponds to the 
flowthrough. Fractions were eluted by a l inear gradient over 20 column volumes from 
0–1 M NaCl as fractions from A1 – H7. Fractions from A) were analysed by 15% 
SDS-PAGE, in which only fractions X1 showed a band of the appropriate size (red 







Figure 2.8 Size-exclusion chromatography purification of recombinant 
Cphy2642. 
Purification from a 120 ml HiLoad 16/600 Superdex column. Fractions A1 – B5 were 
analysed by 15% SDS-PAGE gel (B). A faint band was observed in 





2.1.3 Summary and Discussion 
 
The three putative aldehyde dehydrogenase enzymes from Clostridium 
phytofermentans Cphy1178, Cphy1428 and Cphy2642 were expressed as recombinant 
proteins in E. coli BL21 DE3 cells. Initial expression tests showed that the proteins 
expressed well under standard conditions (37 ºC for 3 hours with shaking at 250 rpm). 
The enzymes were purified in two stages, first by ion-exchange chromatography, over 
a 12 ml Q-sepharose column and further by size-exclusion chromatography, HiLoad 
16/600 Superdex column. 
The enzymes were then used for future experiments, including the aldehyde 
dehydrogenase NAD+ turnover assays and crystal trials. Despite the initial insolubility 
of the full-length protein, the truncated variants stayed soluble at room temperature, 
and so all subsequent steps were carried out at approximately 18 ºC. 
 
2.2      Enzyme activity of acylating aldehyde dehydrogenase enzymes 





The enzyme activity of Cphy_117820-462 had been previously characterized by Thiau 
Fu Ang (Undergraduate honours student, Marles-Wright lab), however there is no 
biochemical data for other BMC associated aldehyde dehydrogenase enzymes 
annotated in the C. phytofermentans genome: Cphy2642 and Cphy1428. It would 
interesting to find out if these enzymes have the same or different substrate 
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specificities as Cphy117820-462, given the fact that they are required for distinct 
pathways and are likely to have different substrates. 
 
2.2.2 Preliminary NAD+ turnover assay set-up 
 
The characterization of these enzymes was performed, with the work on 
Cphy_117820-462 being repeated to try to optimize experimental conditions for the 
other two enzymes. As well as using 2-mercaptoethanol (BME) as a reducing agent to 
ensure the active-site cysteine was in an appropriately reduced state for turnover, 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was also used as a stronger 
reducing agent . However, no data could be generated from these two enzymes despite 
attempts to optimise the experimental set up. It could be the case that acetaldehyde, 
propionaldehyde or butyraldehyde are not the substrates of these enzymes, however 
this is unlikely as inspection of the C. phytofermentans genome suggest that the 
substrates for these enzymes are likely to be intermediates from the breakdown of 
ethanolamine, or choline, which are the likely functions of these BMCs (Petit et al., 
2013). 
 
2.2.3 Enzyme assay set-up 
 
For purified proteins with activity from small-scale assays, enzymes assays were 
carried out to determine kinetic parameters using a 96-well micro-titre plate reader, 
with each well containing 300 µl of reaction buffer. All wells were made up to 300 µl 
volume with 100 mM KCl, 100 mM Tris pH8.0, 0.66 mM β-NAD, and Cphy1178 at 
varying concentrations. For the acetaldehyde assay, 250 nM of Cphy1178, A340 was 
measured every 7 s for 182 s and the assay was carried out in 5 replicates. However, 
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subsequent iterations of the experiment used 100 nM of enzyme, as this gave the best 
overall results in terms of catching the initial turnover step. The assay blank used 
standard assay components without protein. Initial rates from linear regression for 
NADH produced for different substrate concentrations were obtained from data 
analysis. These initial rates produced a curve fitted with non-linear regression applying 
the Michaelis-Menten equation using Prism 6 software (Graphpad), shown in Table 
2.1 and Figure 2.9. 
 
2.2.4 Enzyme assay results 
 
By monitoring the hydride transfer step of the aldehyde dehydrogenase enzyme 
reaction by spectrophotometric measurement of the production of NADH in the 
presence of aldehyde substrates, we were only able to detect NAD+ dependent activity 
for Cphy1178. The other enzymes displayed no distinguishable activity with either 
NAD+, or NADP+, for the substrates used in this study. This may be due to issues 
with the instability of these proteins out of their native environment within the BMC, 
or a requirement for some additional factor not present in our assays. 
We were however able to detect activity against short-chain fatty aldehydes with up to 
seven carbon atoms (Figure 2.9) for Cphy1178, although longer chain aldehydes were 
difficult to assay reliably due to their insolubility in biological buffers and we were 
unable to determine accurate kinetic parameters for C7 and higher aldehydes (Table 
2). Cphy1178 enzyme displayed the lowest KM and the highest kcat/KM values for 
the substrates tested. This data is consistent with the hypothesis that this protein acts 
as a propionaldehyde dehydrogenase within the C. phytofermentans fucose/rhamnose 
BMC. 
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It is noteworthy that this enzyme displays substrate inhibition at high concentrations 
of aldehydes, shown by a decrease in the velocity values in the graphs in Figure 2.9; 
interestingly this is more marked with aldehydes with an odd number of carbon atoms. 
This substrate inhibition is consistent with previous reports on the activity of yeast 
ALDH2 enzyme (Wang et al., 2009). The reason they suggest for this is that at higher 






Substrate Kcat (s−1) KM (mM) kcat/KM (s−1 mM−1) Ki (mM) 
Acetaldehyde 1.62 ± 0.02 5.16 ± 0.10 0.31 n/a 
Propionaldehyde 3.45 ± 0.03 0.82 ± 0.02 4.21 17.31 ± 0.46 
Butyraldehyde 3.44 ± 0.7 1.74 ± 0.07 1.98 144.3 ± 30.2 
Pentanaldehyde 5.44 ± 0.10 2.2 ± 0.7 2.47 12.61 ± 0.46 
Hexanaldehyde 5.61 ± 0.12 2.90 ± 0.10 1.93 23.52 ± 1.28 
Figure 2.9 Activity of Cphy1178 against various aldehyde substrates. 
Cphy1178 was incubated with increasing concentrations of aldehyde substrates in the following reaction mixture: 100 mM Tris.HCl (pH 
8.0); 0.66 mM NAD+, 100 mM KCl, 10 mM 2- mercaptoethanol.  Data were analysed using Graphpad Prism and kinetic parameters were  
calculated by non-linear regression to the Michaelis-Menten equation with substrate inhibition for C3 and larger aldehydes. (Velocity is 
expressed as mM NADH s-1 mM-1ADH). 
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Figure 2.9 Activity of Cphy1178 against various aldehyde substrates. 
Cphy1178 was incubated with increasing concentrations of aldehyde substrates 
in the following reaction mixture: 100 mM Tris.HCl (pH 8.0); 0.66 mM NAD+, 100 
mM KCl, 10 mM 2- mercaptoethanol. Data were analysed using Graphpad Prism 
and kinetic parameters were calculated by non-l inear regression to the Michaelis-
Menten equation with substrate inhibition for C3 and larger aldehydes. (Velocity 
is expressed as mM NADH s-1 mM-1ADH). 






































































2.2.5 Expression and purification of the active site aldehyde 
dehydrogenase variant Cphy1178(20-462) (C269A and H387A) 
 
Based on the identification of the potential catalytic cysteine (Cys269) and histidine 
(His387) residues from a sequence alignment of common aldehyde dehydrogenase 
homologues (described in detail in Chapter 3), these residues were mutated to an 
alanine residue, as this small, non-polar amino acid is unlikely to have any 
involvement in the acylation of an aldehyde substrate, which is the proposed 
mechanism of action for this enzyme. Mutants were generated using site-directed 
mutagenesis (described in Materials and Methods chapter), and were subject to both 
anion exchange and size-exclusion chromatography as in section 2.1.3. Figures 
2.10 and 2.11 show the Size Exclusion Chromatography purification step for both 
variants. The Cphy1178 (C269A) and (H387) variants completely abolished NAD+ 
turnover activity, under the same experimental conditions as the wild-type protein. 
This suggests that these particular residues have an important role, at least in the initial 
NAD+ to NADH turnover step. 
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Figure 2.10 Size-exclusion chromatography purification of recombinant Cphy1178 (C269A) 
variant. 
Fractions B3-D10 were analysed by 15% SDS-PAGE gel. Protein of the correct size 




2.2.6 Summary and discussion 
 
Our initial enzyme assays indicate that Cphy117820-426 is active against a range of 
short-chain fatty-aldehydes (C2-6). The other two proposed aldehyde dehydrogenases 
from the Clostridium phytofermentans genome were inactive under the conditions and 
against all the aldehydes tested. Two active site mutants, C269A and H387A were 
cloned via site-directed mutagenesis, recombinantly expressed and purified under the 
same conditions as the wild-type protein. The variants were also inactive against the 
tested short-chain fatty aldehydes, indicating that both residues have a role to play in 
the turnover of NAD+ to NADH in the cofactor-binding site. Further work to co-
crystallise the wild-type Cphy1178 and both variants, should help further elucidate the 
mechanism of action of the enzyme 
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3 Crystal structure of an acylating aldehyde 
dehydrogenase from Clostridium phytofermentans, with Co-




In the C. phytofermentans genome, there are three putative aldehyde dehydrogenase 
enzymes associated with Bacterial Microcompartment loci: Cphy1178, Cphy1428 and 
Cphy2642 (Petit et al., 2013, 2015). A protein sequence alignment of these proteins 
and a homologue from the PDB (3K9D), as well as the putative aldehyde 
dehydrogenase from the Clostridium difficile ethanolamine utilisation locus 
(CD630_19170), Clostridium beijerinckii (CBS_3832) and Salmonella enterica 
serovar Typhimurium (STM2463) shows there are common conserved residues 
between the three proteins, most notably the catalytic cysteine (C269) and the active 
site histidine residue (H387) (Figure 3.1) Other sequence similarities are the glutamic 
acid (E357) residue, which is part of the NAD+ cofactor-binding site, as well as some 
secondary structure elements, i.e. β-sheet 7 and α-helix 3 (Figure 3.1). Table 3.1 shows 
the sequence identity between the three putative aldehyde dehydrogenase enzymes 
from the C. phytofermentans BMCs, and the PDB structure from Listeria 
monocytogenes, as well as the other BMC aldehyde dehydrogenases mentioned above. 
Interestingly, there is a higher amino acid sequence identity between Cphy1178 and 
aldehyde dehydrogenases from other species (highest Cphy1178 and 5JFN – 54%) 
than between Cphy1178 and the other putative AldDHs from C. phytofermentans, 
Cphy1428 and Cphy2642 (30% and 31% respectively). The highest level of sequence 
identity is between 3K9D from L. monocytogenes and Cphy2642. The higher level of 
sequence identity between Cphy1178 and the 5JFN PDB homologue could be 
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explained by the fact that this enzyme is also a propionaldehyde dehydrogenase, which 
Cphy1178 was shown experimentally to be in Chapter 2. 
 Cphy1178 Cphy1428 Cphy2642 3K9D CBS_3832 STM2463 CD630_19170 5JFN 
Cphy1178 100        
Cphy1428 30 100       
Cphy2642 31 49 100      
3K9D 30 49 66 100     
CBS_3832 52 28 30 28 100    
STM2463 42 31 33 31 44 100   
CD630_19170 30 50 64 64 28 32 100  
5JFN 54 31 31 32 51 45 32 100 
Table 3.1 Amino acid sequence identity (%) between aldehyde dehydrogenases from 
different bacterial species. 
Sequence identity was calculated using a BLASTp alignment. Protein sequences 
were taken from KEGG or from the protein PDB entry 
 
The aldehyde dehydrogenase enzymes form a key part of the sugar breakdown 
pathways in BMCs in various bacterial species (Yeates et al., 2013), as they turn over 
the reactive aldehyde intermediates within these pathways to generate useful acyl- 
CoA derivatives (Leal et al., 2003). The AldDH enzymes have been shown to have a 
Rossmann-fold nucleotide binding domain that positions an NAD(P)+ in the suitable 
conformation for hydride transfer from the aldehyde substrate (Liu et al., 1997) 
Although there is a glutamic acid residue (E357) in the NAD+ active site, it is not in 
the correct conformation to act as a general base to resolve the acyl-enzyme 
intermediate to the free acid, and so it is likely that another cofactor, Co-enzyme A 
(CoA) is used to resolve this intermediate (Shone and Fromm, 1981). Up until now 
there were no structures of an acylating aldehyde dehydrogenase with the CoA 
cofactor shown in the active site. This chapter looks at the X-ray crystallographic 
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structures of Cphy1178(20-462), the C269A and H387A variants with NAD+ and CoA in 
the cofactor binding site, and a final active site variant, E357A, to confirm the overall 





Figure 3.1 Multiple sequence alignment of aldehyde dehydrogenase enzymes used in this study 
and close homologues. 
Sequence alignment generated using ClustalΩ (Sievers and Higgins, 2014) and 
displayed using ESPript(Gouet et al., 2003). Secondary structure elements of 
Cphy_1178 are shown above the alignment.  
 
3.1.1 Crystallisation of Cphy1178(20-462) and active site variants 
 
For crystallisation trials, the untagged and truncated variant for each construct was 
purified by anion exchange and the size exclusion chromatography (described in 
Chapter 2) and was concentrated to between 8-12 mg/ml, with protein concentration 
estimated based on calculated extinction coefficients at 280 nm. Proteins were initially 
screened for crystallisation against a range of commercial screens and optimised 
around conditions from the JCSG+ suite (Materials and Methods). Once suitable 
crystallisation conditions had been found for both Cphy1178(20-462) and the active site 
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variants (0.1 M sodium acetate pH4.7, 1.8 M ammonium sulfate), crystals were 
harvested, and data collected and refined as described in Materials and Methods. Table 
3.2 shows the X-ray data and refinement statistics. Figure 3.2 shows the bi-pyramidal 



























Figure 3.2 Images of bi-
pyramidal Cphy1178(20-462) 
and variant crystals. 
Images taken with a 
Leica DFC450 C digital 
microscope at 10X 
resolution from Linbro 
24-well optimisation 
plates A)Cphy1178(20 -
462), crystals B) and C) 
are the C269A variant 
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 Cphy1178(20–462) 
NAD+ C269A-CoA H387A E357A 
Data Collection  









49.8 - 1.851 
(1.917 - 1.851) 
Space group I 41 2 2 I 41 2 2 I 41 2 2 I 41 2 2 

















(24,674) 40,079 (2229) 24,570 (2,389) 34835 (3415) 
Multiplicity 6.0 (6.0) 12.9 (11.4) 10.0 (9.7) 14.6 (14.0) 
Completeness 
(%) 99.7 (99.9) 99.9 (98.5) 98.85 (99.25) 99.95 (99.94) 
Mean I/sigma(I) 17.8 (2.3) 22.4 (2.3) 18.94 (1.63) 24.08 (1.41) 
Wilson B (Å2) 16.52 24.95 40.85 33.57 
Rmerge 0.062 (0.697) 0.073 (1.050) 0.081 (1.227) 0.08105 (1.889) 
Rmeas 0.074 0.079 (1.152) 0.08496 0.084 (1.96) 








9 Not published 
Model Building and Refinement 














Number of non- 
hydrogen atoms 3795 3597 3376 3659 
macromolecules 3293 3225 3245 3277 
ligands 69 79 5 78 
water 433 293 126 242 
Protein residues 435 431 435 439 
RMS(bonds) (Å) 0.011 0.010 0.015 0.011 
RMS(angles) (°) 1.37 1.26 1.44 1.34 
Ramachandran 
favored (%) 99 99 98 98.38 
outliers (%) 0 0 0 0 
Clashscore 2.66 0.45 4.42 3.56 
Average 
B-factor (Å2) 24.90 33.90 56.80 38.60 
macromolecules 23.90 32.50 57.10 37.27 
ligands 28.30 79.8 80.8 85.51 
solvent 32.10 37 46.50 41.54 
PDBID 4C3S 5DBV 5DRU Not deposited 
Table 3.2 X-ray data collection and refinement statistics for Cphy1178 protein and 
active-site variants. 
Statistics for the highest-resolution shell are shown in parentheses. 
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3.1.2 Structure of Cphy1178(20-462) 
 
To understand the co-factor binding properties of Cphy1178, the structure of an N- 
terminal truncation was determined, comprising residues 20 – 462, with bound NAD+ 
cofactor to 1.6 Å resolution (Tuck et al., 2016). In these structures, the asymmetric 
unit contains a single chain with residues 28 to 462 visible in the electron density map. 
The overall structure corresponds to other members in the aldehyde dehydrogenase 
family (Figure 3.3A), with a catalytic domain (residues 238 – 427, highlighted pink), 
a co-factor-binding domain with a Rossmann-fold nucleotide binding architecture 
(residues 28 – 108, 127 – 237, and 428 – 447, highlighted grey), and an oligomerisation 
domain (residues 109 – 126 and 448 – 462, highlighted green). The catalytic and 
nucleotide binding domains come together to form an extended nucleotide and ligand-
binding tunnel that is open at both ends, with the catalytic cysteine (C269) at the centre 
of the tunnel and the NAD+ cofactor binding at one side (Figure 3.3B). The ligand-
binding tunnel is about 5 Å in diameter at its widest point and spans 16 Å from the 
solvent exposed entry point to the catalytic cysteine and is lined with hydrophobic 
residues. The tunnel is long enough to accommodate up to a C10 aldehyde, although 
in vivo the enzyme is unlikely to encounter such a substrate. 
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Figure 3.3 Structure of Cphy1178(20-462) 
A) Secondary structure cartoon of a monomer of Cphy1178(20 -462) showing bound 
NAD+ as spheres coloured yellow for carbon, red for oxygen, blue for nit rogen and 
orange for phosphorus. The catalytic domain is highlighted pink, Rossmann-fold 
nucleotide binding domain in grey and oligomerisation domain in green. B) Active 
site tunnel and nucleotide binding pocket. The surface of Cphy1178(20-46 2) is shown 
coloured by electrostatic potential (blue for positive, red for negative) and the 
secondary structure cartoon is shown in blue. The catalytic cysteine and histidine 
residues are shown as sticks. Bound cofactors, NAD+ and CoA are shown with yellow 
and pink carbons respectively.  C) Cphy1178 forms a dimer of dimers quaternary 
structure. Two subunits are shown as cartoons, wi th NAD+ shown as spheres to show 
the relative orientation of the nucleotide-binding cleft; two further subunits are 
shown as grey surface representations (Tuck et al., 2016) 
 
3.1.3 Structure of Cphy1178(20-462) C269A and H387A variants 
 
The structure of Cphy1178 was also determined in a number of active site variant 
forms: C269A with bound CoA (1.77 Å resolution) and H387A (2.08 Å resolution) to 
ensure that mutation of these residues did not destabilise the structure of the protein 
and to probe the active site. Both proteins displayed essentially identical structures to 
the wild-type protein. In the structure of the Cphy1178C269A variant the position of 
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the loop between 335 and 339 was not clear in the electron density maps, so was 
omitted from the final structure refinement. 
 
3.1.4 Co-factor binding 
 
The structure of Cphy1178(20-462) was determined with NAD+ bound in the nucleotide 
binding cleft and active-site pocket after soaking apo-crystals with crystallization 
solution supplemented with 10 mM NAD+. The ligand displayed excellent electron 
density (Figure 3.5A) and was refined to an occupancy of 0.83 in the final structure 
using phenix.refine. The NAD+ is found in the hydride transfer conformation 
(Bateman et al., 2003; Perez-Miller and Hurley, 2003) and participates in 4 direct 
hydrogen bonding interactions with the enzyme and a number of other interactions 




Figure 3.4 Surface views of cofactor binding to Cphy1178(20-462). 
A) Comparison of co-factor positions in Cphy1178(20-462) with NADP+ position in 
PDBID:4NMJ. Electrostatic surface shown for 4NMJ and carbon atoms of NADP+ 
shown in blue. B) Space- fi l l ing view of NADP+ bound to 4NMJ. C) Top view of 
adenine binding pockets in Cphy1178(20- 46 2) .  NAD+ shown with blue carbon atoms, 
CoA shown with magenta carbons. D) Space-fi l l ing representation of NAD+. E) 
Oblique view of adenine binding pockets depicted as in C). F) Space-fi l l ing 





Figure 3.5 Stick representation of NAD+ binding in the cofactor binding site. 
Hydrogen bonding interactions shown as a blue dashed line. NAD+ molecule in grey 
and Cphy1178(20-264) shown in white. Blue circles highlight the catalytic C269 
residue, the nicotinamide ring and the I433 residue. PDB ID 4C3S and (Tuck et al., 
2016), NGL Viewer (Rose et al., 2018) NGL viewer: web-based molecular graphics 




The adenine ring does not directly participate in any hydrogen bonding interactions, 
but it is positioned between Leucine 198 and Valine 221. The N7 of the adenine ring 
accepts a hydrogen bond from an ordered solvent molecule that is also coordinated by 
an oxygen atom in the adenosine phosphate group and the backbone nitrogen of Valine 
221. Both O2 and O3 of the adenosine ribose interact with an ordered water molecule 
that bridges them to the carbonyl oxygen of Proline 161. Similarly, two oxygen atoms 
from the phosphate groups are bridged to Histidine 162 via a solvent molecule. 
Glutamine 357 participates in hydrogen bonding interactions with O2 and O3 of the 
nicotinamide ribose. The nicotinamide ring is positioned next to the catalytic Cysteine 
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269 through hydrogen bonding interactions between N7 and O7 and the peptide 
backbone of Isoleucine 433 (Figure 3.5). The absence of enzymatic activity in the 
presence of the NADP+ co-factor is explained by the presence of a histidine and proline 
residue blocking the position that the 2’-phosphate adopts in structures of aldehyde 
dehydrogenase enzymes determined with NADP+ bound (Figure 3.6A/B). 
 
Figure 3.6. Wall-eyed stereo view of electron density maps of bound NAD+ and CoA cofactors. 
A) Structure of NAD+ soaked Cphy1178(20 -462).  NAD+ and protein residues within 4 Å 
shown as stick representations and 2mFo-DFc map shown as a blue mesh contoured 
at 1σ. B) Structure of CoA soaked Cphy1178(20-46 2)C269A displayed as in A) (Tuck 
et al., 2016).  
  
The structure of Cphy1178(20-462) C269A was determined using crystals soaked with 
10 mM CoA. The cofactor showed good electron density for the adenosine group, but 
poor density for the pantothenic acid group, particularly the terminal region with the 
sulfydryl group in the active site, which has no visible electron density (Figure 3.6B). 
A comparison of the structure of the NAD+ and CoA bound forms of the protein show 
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that the structures are essentially identical, with an rmsd Cα of 0.24 Å over 431 
residues. The two structures differ only in the position of the loop between residues 
215 and 223, where P219, G220 and V221 are shifted toward the adenine ring in the 
NAD+ -bound structure (Figure 3.7). In contrast to the models of CoA binding to the 
Pseudomonas DmpF aldehyde dehydrogenase (Lei et al., 2008) and Lactobacillus 
reuteri PduP aldehyde dehydrogenase (Sabet-Azad et al., 2013) this crystal structure 
shows distinct adenine-binding modes for NAD+ and CoA . The adenine ring is flipped 
by 180 degrees relative to its position in the NAD+ structure and makes hydrogen-
bonding contacts with both the side chain and carbonyl oxygen of Asparagine 160, 
and the carbonyl oxygen of Threonine 134, placing the phospho-ribose group above 
both of the nucleotide binding pockets. The phosphate groups between the nucleotide 
and pantothenate group are held in place by hydrogen bonds formed between the side-
chain nitrogen atoms of Histidine 162 and Arginine 318. While there is clear electron 
density for the nucleotide and phosphate-proximal portion of the pantothenate group 
of the CoA the β-mercapto- ethylamine group is not visible, indicating that the distal 
arm of CoA is flexible in the absence of thio-acyl substrates bound to the catalytic 




Figure 3.7 Wall-eyed stereo view of cofactor binding within the nucleotide- binding domain of 
Cphy117820-462. 
Stereo ribbon representation of the proteins and stick representations of the NAD+ 
and CoA cofactors are displayed to show the minor difference between the two 
cofactor bound structures of Cphy1178(20-462). The helix highlighted in pink, 
between residues 215 and 225 is shifted slightly in the CoA bound structure (purple) 





3.1.5 Proposed mechanism of action of Cphy1178(20-462) 
 
We have shown that Cphy1178 shows a higher level of activity with propionaldehyde 
as a substrate compared to other aldehydes tested and is capable of acyl-transfer to 
CoA using this substrate. We have also determined the structure of this enzyme with 
CoA bound in the active site.  The acylating aldehyde dehydrogenase family enzymes 
do not possess the glutamic acid general-base that is required to activate the catalytic 
cysteine and to deprotonate water for deacylation of the acyl-enzyme intermediate. In 
Cphy1178 this residue is replaced by an alanine (A235) and is a small hydrophobic 
residue in all of the acylating aldehyde dehydrogenases shown in Figure 3.1. 
Mutagenesis of a strictly conserved Histidine residue (H387) (Figure 3.1), completely 
abolishes activity of the enzyme. This residue is not found in any of the non-acylating  
aldehyde dehydrogenase enzymes. The proximity of this residue to the catalytic 
cysteine is incompatible with the formation of the correct geometry for deprotonation 
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of water for resolution of the acyl-intermediate to produce a carboxylic acid product. 
The biochemical data showing that the H387A variant is inactive, suggests that this 
residue acts as a base to activate the catalytic cysteine and to stabilise the acyl-transfer 
intermediate between the enzyme and CoA cofactor. Due to the proximity of a 
glutamic acid residue (E357) to the cysteine group of CoA and the strict conservation 
of this residue, a model is proposed in which this residue activates the CoA cofactor 
for acyl transfer from the acyl- enzyme intermediate (Figure 3.8). The reaction scheme 
shows H387 deprotonates the catalytic cysteine to allow nucleophilic attack on the 
substrate to form tetrahedral intermediate. Consistent with previous reports the 
oxyanion would be N138. After hydride transfer to NAD+, the NADH product leaves 
the cofactor-binding pocket in the rate-limiting step, followed by entry of CoA, which   
is deprotonated by E357 and subsequently attacks the acyl-enzyme intermediate to 
produce the thioester product and free enzyme (Figure 3.8). The extra proton on E357 
is likely transferred to bulk water via a proton-relay system comprising the conserved 




Figure 3.8 Proposed catalytic mechanism of Cphy1178. 
The catalytic cycle proceeds via a bi-uni-uni-uni-ping-pong mechanism involving  
acylation of the catalytic cysteine (C269) and hydride transfer to NAD+ , followed by 
trans-thioesterification between the enzyme and CoA to produce the acyl-CoA 
product. A ping-pong mechanism, also known as a double displacement reaction, is  
characterised by the enzyme changing to an intermediate form during the first  
substrate to product reaction (Tuck et al., 2016).  The bi- and uni- prefixes refer to 
the number of substrates and products, so two and one respectively (Cleland, 1963).  
 
Interestingly, a recent paper from (Zarzycki et al., 2017) shows the crystal structure of 
an acylating prionaldehyde dehydrogenase from Rhodopseudomonas palustris, with 
CoA or propionyl-CoA in the active site (Zarzycki et al., 2017). Unlike in the 
mechanism proposed here, they observed that the S-propionylcysteine assumes a 
different rotamer confirmation than the non-acylated cysteine, which prevents the 
interaction of the CoA with the conserved glutamate residue (E357). They suggest that 
two conserved water molecules are responsible for the deprotonation of CoA. To test 
whether the glutamic acid residue E357 is responsible for the deprotonation of CoA, a 
variant of the Cphy1178(20-462) was generated, replacing the glutamate residue with 
an alanine residue. The variant was expressed, purified and crystallised as in described 
in Chapter 2 and earlier in this chapter. 
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3.1.6 Structure of Cphy1178(20-462) E357A variant 
 
The structure of the E357A variant was almost identical to the wild-type version of the 
protein. Interestingly, although the crystals were not soaked with the CoA cofactor, 
there was electron density in the structure that fitted for the adenine ring (Figure 3.9 
and 3.10). This suggests that CoA has been trapped within the active site, as it has not 
been able to deprotonate due to the lack of glutamic acid residue to carry out the acyl-
transfer step. The conserved water molecules described in Zarzycki et al. (2017), were 
also not observed, leading back to the proposed mechanism of the conserved glutamic 
acid residue deprotonating the CoA thiol. 
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Figure 3.9 Architecture of cofactor binding to Cphy1178(20-462).   
Surface slice through Cphy117820–462 showing the position of NAD+ from (PDB ID 
4C3S) (green), the CoA from Rhodopseudomonas palustris (PDB ID 5JFN) and the 
CoA from Cphy1178 (E357A) (pink).  Protein residues shown as sticks in the co-
factor binding tunnel, shown as an electrostatic surface. 
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Figure 3.10. Electron density map of potential bound CoA cofactor 
Structure of CoA (yellow sticks) modelled in the Cphy1178(20-462).E357A variant 
(pink sticks).  Enzyme and CoA shown as stick representations and 2mFo-DFc map 
shown as a blue mesh contoured at 1σ. 
 
3.1.7 Summary and discussion 
 
The crystal structures of Cphy1178(20-462) (4C3S) and the variants C269A (5DBV), 
H387A (5DRU) and E357A (undeposited) were solved with either NAD+ or the Co- 
enzyme A co-factor modelled in the Rossmann-fold nucleotide binding domain. The 
active site variants were almost identical to the wild-type protein structurally; however 
the C269A and H387A variants were found to be inactive (Chapter 2). This data helped 
to propose a mechanism of action for the enzyme, whereby the H387 deprotonates the 
catalytic cysteine to allow nucleophilic attack on the substrate to form a tetrahedral 
intermediate. After hydride transfer to NAD+, the NADH product leaves the cofactor-
binding pocket in the rate-limiting step, followed by entry of CoA, which is 
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deprotonated by E357 and subsequently attacks the acyl- enzyme intermediate to 
produce the thioester product and free enzyme. Along with the biochemical data shown 
from Chapter 2, Cphy1178 is proposed to be a propionaldehyde dehydrogenase and 
confirms the reaction scheme proposed in (Petit et al., 2013)(Figure 3.11). 
 
 
Figure 3.11 Scheme for Clostridium phytofermentans fucose/rhamnose utilisation pathway. 
Pathway intermediates and cofactors shown with proposed aldehyde dehydrogenase 
(Cphy1178) and alcohol dehydrogenase (Cphy1179) shown in red. Scheme based 
on (Petit et al., 2013).  
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Although there are conflicting ideas on the official definition of synthetic biology, a 
general view is that it is ‘the rational design of biological systems and living organisms 
using engineering principals’ (Osbourn et al., 2012). Bacterial microcompartments 
have certain properties that make them potentially useful tools in synthetic biology, 
raising solutions to common bioengineering problems. 
They are modular, have compact organization, and are found in a wide variety of 
ecological niches including plant-associated and pathogenic bacterial species, so could 
be relevant in both the development of biofuels (Machado and Atsumi, 2012), as well 
as a target in the battle against antibiotic resistance (Chowdhury et al., 2014). 
With the emergence of tools for synthetic biology, it is possible to generate large DNA 
libraries quickly and cost-effectively. Standard cloning can be time-consuming and is 
a main stumbling block in a molecular laboratory workflow; however, the last decade 
has seen the development of simple one-pot restriction/ligation methods based on Type 
IIs restriction endonucleases that cut outside of their recognition sites, such as the 
Golden Gate method (Engler et al., 2008)A number of standards for DNA assembly 
and part design have been produced in the last few years (Engler et al., 2009, 2014; 
Moore et al., 2016; Sarrion-Perdigones et al., 2011; Weber et al., 2011; Werner et al., 
2012) including the CIDAR Modular Cloning toolkit (MoClo), developed by the 
Densmore laboratory in Boston (Iverson et al., 2015). The toolkit, which was the first 
bacterial MoClo parts library is available publicly through Addgene. This kit consists 
of a series of plasmids containing different strength promoters, ribosome binding sites 
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(RBSs), open reading frames (ORFs) for a range of fluorescent reporter genes, 
terminators and plasmids for transcriptional units. The premise of this toolkit is 
described in detail in Chapter 1.5; however, it is important to note that the flexibility 
offered by this kit is central to this study into building bacterial microcompartments as 
tools for synthetic biology. The iterative synthetic biology workflow, illustrated in 
Figure 4.1: of designing, building, testing, learning and using the constructs generated, 
were used in the following parts of this project. 
 
Figure 4.1. The synthetic biology workflow (Myers et al., 2017). 
  
The aims are: 
 
1. To use the CIDAR MoClo toolkit to construct a shell protein library to develop 
various transcriptional units with different numbers of shell proteins from different 
bacterial species, with a view to expressing and visualizing these synthetic 
microcompartment shells with thin-section electron microscopy and ultimately using 










2. To design forward engineered ribosome binding site and localisation sequence 
fusion-constructs using the BMC localisation sequences from the Salmonella and C. 
phytofermentans Pdu microcompartments. The rationale behind this is to find out if a 
fixed protein part downstream of the different strength RBSs will lead to differing 
expression levels of fluorescent reporter, or if there is a particular strength RBS that 
will be optimal for production of the reporter. This can be used in further studies to 
test the targeting of a specific amount of protein to a microcompartment. 
3. To use the Golden-Gate modified pET28a vector to clone and express the 
EutM shell proteins from different bacterial species. Overexpressed shell proteins can 
either be crystallised to look at the surface residues and charge more closely, or the 
structures can be shown by thin-section microscopy 




The different sizes and charges of the bacterial microcompartment shell proteins can 
greatly affect microcompartment formation, as can the differing charge states around 
the pore allowing for influx of different BMC pathway molecules (Crowley et al., 
2008; Pitts et al., 2012; Zarzycki et al., 2015). Efforts have been made to rationally 
design synthetic microcompartment shells for various uses, although the general idea 
is to target novel enzyme pathways to microcompartment shells, for either increased 
enzyme efficiency or to sequester toxic, or volatile, molecules away from the bacterial 




4.2.2 Shell proteins in Clostridium phytofermentans fucose/rhamnose and 
Salmonella Pdu BMCs 
 
There are six putative bacterial microcompartment shell proteins encoded on the 
Clostridium phytofermentans fucose/rhamnose BMC locus, and seven on the 
Salmonella Pdu BMC locus. The Pfam domains of each of these proteins are shown in 
Table 4.1, along with the ethanolamine utilisation microcompartment homologues. 
 
Shell protein Pfam domain Protein homologue(s) 
Cphy_1176 00936 EutS 
Cphy_1180 00936 - 
Cphy_1181 00936 - 
Cphy_1182 00936 - 
Cphy_1184 03319 EutN/CcmL 
Cphy_1186 00936-00936 - 
STM2038 (PduA) 00936 EutM 
STM2039 (PduB) 00936-00936 - 
STM2045 (PduJ) 00936 EutM 
STM2046 (PduK) 00936 - 
STM2049 (PduN) 03319 EutN/CcmL 
STM2054 (PduT) 00936-00936 - 
STM2055 (PduU) 00936 EutS 
Table 4.1 BMC shell proteins from Clostridium phytofermentans and 
Salmonella enterica used in this study. 
The protein homologues were found on the KEGG GENE database. 
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The BMC shell proteins fall into three distinct domain families, BMC-H, BMC-T and 
BMC-P (Lassila et al., 2014). The majority of the shell proteins are BMC-H type 
domains, indeed this is the most common type among all BMCs so far. A sequence 
alignment of the BMC-H–type proteins (Pfam 00936) against the EutM homologue 
(PDBID:4AXJ) from Clostridium difficile (Pitts et al., 2012)is shown in Figure 4.2. 
 
Figure 4.2 Multiple sequence alignment of the BMC-H type shell proteins used in this study, 
aligned against the EutM homologue from C. difficile. 
The sequence alignment was generated using ClustalΩ (Sievers and Higgins, 
2014)and displayed using ESPript (Gouet et al., 2003)4AXJ is the PDB code for the 
EutM homologue from C. difficile; the corresponding secondary structure elements 
from 4AXJ are shown above the alignment.  
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The β1-strand is relatively well conserved between the different BMC-H proteins, with 
a high level of conservation of the Gly8 residue. The Lys27 residue in CD1918 (α1) is 
shown to be involved in the crystal-packing region of the protein (Pitts et al., 2012) 
and again this residue is highly conserved between the BMC-H proteins shown in 
Figure 4.2. 
 
Figure 4.3 Multiple sequence alignment of the BMC-P type shell proteins used in this study, 
aligned against the EutN homologue from E. coli. 
The sequence alignment was generated using ClustalΩ (Sievers and Higgins, 2014) 
and displayed using ESPript (Gouet et  al.,  2003). 2HD3 is the PDB code for the EutM 
homologue from E. coli;  the corresponding secondary structure elements from 2HD3 
are shown above the alignment.  
 
The BMC-P-type proteins (Pfam 03319) were aligned against the EutN homologue 
from E. coli (Forouhar et al., 2007) (Figure 4.3). This shell protein type contains a 
five-stranded β-barrel, with an α-helix at the open end. There is a higher level of 
conservation between the two BMC-P-type proteins and the EutN homologue, than 
between the BMC-H-type and their EutM homologue. 
The BMC-T-type protein alignment is shown in Figure 4.4. This particular homologue 
has been engineered to contain a 4Fe-4S cluster binding site (Aussignargues et al., 
2016), although itself is a homologue of the PduT from Citrobacter freundii The 
STM2039 BMC-T protein is almost double the size of the other proteins in this 
alignment, however it still has alanine and glycine residue conservation in the β-1 
strand. Overall these alignments show that there are some common conserved residues 
between the different shell protein types, mainly in the β1-strand. 
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Figure 4.4 Multiple sequence alignment of the BMC-T-type shell proteins used in this study, 
aligned against the PduT homologue from Citrobacter freundii. 
The sequence alignment was generated using ClustalΩ (Sievers and Higgins, 2014) 
and displayed using ESPript (Gouet et al. , 2003). 5DIH is the PDB code for the PduT 
homologue from Citrobacter f reundii; the secondary structure elements from 5DIH 
(Aussignargues et al. , 2016) are shown above the alignment.  
  
4.2.3 Establishing the MoClo DNA assembly pipeline for the production of 
synthetic BMCs 
 
The Benchling software (available at Benchling.com) was used to design and test the 
assembly of all constructs in silico, including the initial primers used to clone the shell 
protein constructs (listed in Table 4.1), into the Level 0 plasmid. Both the PCR and 
digestion reactions were first checked in silico using the Benchling software, before 
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the primers were ordered. This step cuts down on cloning error due to weak/incorrect 
primer design and is an important part of the synthetic biology workflow. One of the 
BMC shell proteins, Cphy_1182 had an internal BpiI site, which needed to be mutated 
before this particular construct could be cloned into the Level 0 plasmid described in 
Materials and Methods 
A design feature lacking from the MoClo toolkit parts was a series of common C- 
terminal protein tags, as well as a double stop codon to ensure ribosome detachment 
during protein translation and stop ‘stop codon read-through’. Primers were designed 
to add His6, Strep, HA, and FLAG tags to the 5’ end of the terminator constructs, such 
that in-frame codon reads would produce a tagged version of the protein coded in the 
upstream part. The PCR primers and detailed protocol for this method are described 
in Materials and Methods. 
 
4.2.4 Rational design of shell protein constructs 
 
Two interesting questions with respect to bacterial microcompartment shell formation 
are: 
• Do the differences with respect to the BMC shell protein pores make chimeric 
synthetic microcompartments more effective when targeting specific synthetic 
enzymes and pathways to them? 
• Does a shell protein’s position on within the transcriptional unit affect the 
overall structure of the microcompartment shell? 
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Figure 4.5 SBOL images of shell protein constructs, designed with Benchling software and 
generated using the modular cloning (MoClo) toolkit, in a one-pot assembly method. 
A) A shell protein in the Level  0 ampicil l in vector. B) A list of MoClo toolkit parts,  
including constitutive and controllable promoters (red arrows), high, medium and low 
strength RBSs (yellow semi-ci rcles), fluorescent reporter genes (GFP and RFP in 
example above, green and red boxes respectively) and a series of terminators with 
different 3’ overhangs for di fferent levels of  the system (black T). C) A level  1 
transcriptional  unit,  including an RBS ‘spacer’ part (black vertical l ine) to ensure 
equal expression levels of individual shell proteins (purple, blue and light green 
boxes). D) A level 2 transcriptional unit made from a ligation of two level 1 
transcriptional  units.  The different levels in the system allow larger constructs to be 
built, as a one-pot reaction success tends to drop with l igation of more than six 
molecules/one-pot reaction. 
  
Despite it not being possible within the scope of this project to express any shell 









Table 4.2 Rational design of shell protein level 1 transcriptional units.  
P=Promoter, R=RBS, S=Shell protein (colour differentiation to make design clearer),  
T=Terminator 
 
Although the one-pot, Golden-Gate cloning is beneficial to generating this large 
number of constructs quickly, it is important to note that due to the design of the 
overhangs, it is not possible to control the order that the shell proteins are inserted into 















































































































































































































































































































































































4.2.5 Summary and discussion 
 
Shell protein constructs were cloned into the MoClo toolkit Level 0 plasmids, with a 
view to building them into rationally designed transcriptional units, to study 
microcompartment shell formation. A series of terminator tags were cloned into the 
MoClo system, to make generating tagged constructs faster and more effective. Future 
work on this project would see a range of BMC shell protein cloned into the Toolkit, 
including Eut and Etu microcompartment proteins. 
 




For the assembly of BMCs, the question of how shell proteins are formed is also the 
question of how are the pathway enzymes targeted to the BMC? The two are not 
thought to be mutually exclusive, as a popular model for BMC assembly shows the 
core pathway enzymes recruiting the shell proteins via an encapsulation peptide, also 
known as a localisation sequence (Kerfeld et al., 2018). The localisation sequences 
from some of the key aldehyde dehydrogenases have been shown in Jacobson et al. 
(2015). An interesting paper from Fan et al. (2012) shows that the Salmonella enterica 
PduP enzyme (STM2051) localisation sequence interacts with the PduA shell protein 
via the Glu7, Ile10 and Leu14 residues, and that this interaction is critical fro the 
encapsulation of PduP into the BMC (Fan et al., 2012). Using the principal of enzyme 
encapsulation via the N-terminal localisation sequence, here the design of forward 
engineered ribosome binding site and localisation sequence-fused constructs from the 
PduP enzyme from Salmonella enterica, as well as the Cphy1178 aldehyde 
dehydrogenase is shown, along with generation of transcriptional units containing a 
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green fluorescent protein (GFP) or PhiLov reporter, to look at quantifying enzyme 
targeting to the bacterial microcompartment. 
 
4.3.2 RBS + Cphy1178/STM2051 localisation sequence construct design 
 
The RBS + localisation sequence constructs (RBS+loc) were designed to have 
different binding strengths (1X, 10X, 100X and 1000X) using the Howard Salis 
Ribosome Binding Site Calculator software. The constructs were ordered as 
complementary primers with suitable overhangs, annealed at 95ºC and subsequently 
cloned into the Level 0 B-C overhang plasmid (described in detail in Materials and 
Methods). 
 
Figure 4.6 SBOL representation of RBS+loc construct transcriptional unit with fluorescent 
reporter gene. 
The controllable/constitutive promoters and GFP are taken from the MoClo toolkit.  
Philov fluorescent reporter adapted for the MoClo system by Efrain Zarazua-Arvizu 
in the Marles- Wright Laboratory. Terminator and tag construct developed as 
described in section 4.2.3. 
 
To correctly assay whether GFP had been encapsulated into the BMCs, and not just 
localised to the cytosol, two different ssrA-tags were cloned into the terminator 
plasmids from the Toolkit, to add a C-terminal degron to the fluorescent reporter 
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proteins. The ssrA –tags are recognised by the AAA+ ClpXP and ClpAP proteases and 
target the protein for degradation (Purcell et al., 2012). 
Many Level 1 transcriptional units were generated for this project (Table 4.3). 
Preliminary data is shown for some of the constructs generated in section 4.1.3.3, 
however, further work on this project would refine the cell growth and GFP expression 
protocols, as described in (Wang et al., 2011). 
 





1 Controllable All GFP Stop E. coli LB Plate reader 






3 Constitutive All GFP Stop E. coli LB Plate reader 



































Table 4.3 Transcriptional units generated with the RBS+loc constructs. 
Controllable promoter = R0010_AB (Toolkit  part), Constitutive promoter = 
J23100_AB (Toolkit part), All = STM2051 and Cphy1178 (1X, 10X, 100X, 1000X) 
RBS+loc constructs, LVA and LAA degron tags design described in section 4.1.3.2. 
Expression system refers to the bacterial species with which the plasmid was 
transformed. 
 
The main aim for this section of the project is to quantify in real-time, the number of 


















Figure 4.7 The design, build, test, learn, use synthetic biology workflow cycle as related to the 
RBS+loc sequence constructs. 
Colours refer to Figure 4.1, and the different stages of the synthetic biology 
workflow. Ideally the construct design stage should drastically cut down bench-time, 
with efficient design protocols allowing for a quick and effective cloning process. 
 
fluorescence activated cell sorting (FACS), and to see if rationally designed RBS 
strength ultimately has an effect on the amount of GFP localised to the 
microcompartments. However, initial parameters first have to be established to 
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promoter. The workflow in Figure 4.7 shows the different stages of designing, 
building and testing these synthetic RBSs. 
 
4.3.3 RBS + Cphy1178/STM2051 localisation sequence plate reader 
assays 
 
The first transcriptional units designed for this section of the project used the 
controllable LacI promoter (R0010_AB) from the MoClo toolkit, the Cphy1178 RBS 
constructs (1X, 10X, 100X, 1000X), the GFP reporter gene, and the double-stop- 
modified Toolkit terminator. The constructs were transformed into the BL21 E. coli 
lac expression strain, and were cultured at 37ºC in LB medium. Figures 4.8, 4.9 and 
4.10 show the results of these growth assays after 20 hours, with varying levels of 
IPTG. 
 
Figure 4.8 Time-course OD600 growth curves using construct TU1 from Table 4.3  
E.coli cells were grown in LB broth at 37ºC with shaking at 225rpm in a 96 well plate,  
with a starting OD600 0.01 and letting the cells grow to stationary phase. OD600 
was monitored using a plate reader (SpectraMax M5). Cells were supplemented with 
different concentrations of IPTG (0.5 mM and 1 mM) to look at effect on GFP 
expression levels.  
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The OD600 measurements after 20 hours showed a standard sigmoidal growth curve 
typically expected for E.coli growth, with an apparent lag phase, log phase and 
stationary phase (Figure 4.8). The FL/OD600 curves show a dip at around the 5 hour 
mark for all constructs at the three different IPTG concentrations (Figure 4.10), with 
these values then rising to between 400 and 600 units after 20 hours. The GFP 
fluorescence was measured between wavelengths 485-538 nm. An initial reading of 
purified GFP protein was used to calibrate the fluorescence, however the values shown 
in Figure 4.9 are a lot lower than would typically be expected for this type of assay 
(Wang et al., 2011). This may be due to an error in construct design, although this is 
unlikely due to the prior in silico testing of the constructs. The GFP emission peak 
should be around 509 nM so is well within the range measured in the assay. 
 
Figure 4.9 Time-course FL485-538 curves using construct TU1 from Table 4.3  
E.coli cells were grown in LB broth at 37ºC with shaking at 225rpm in a 96 well plate,  
with a starting OD600 0.01 and letting the cells grow to stationary phase. FL485-
538 was monitored using a plate reader (SpectraMaxM5). Cells were supplemented 
with different concentrations of IPTG (0.5 mM and 1 mM) to look at affect on GFP 
expression levels.  
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Figure 4.10 Time-course FL485-538/OD600 growth curves using construct TU1 from Table 4.3 
E.coli cells were grown in LB broth at 37ºC with shaking at 225rpm in a 96 well plate,  
with a starting OD600 0.01 and letting the cells grow to stationary phase. OD600 
and FL485-538 was monitored using a plate reader SpectraMaxM5. Cells were 
supplemented with different concentrations of IPTG (0.5 mM and 1 mM) to look at 
affect on GFP expression levels.  
 
Figure 4.11 shows the comparison of the different promoter strengths at 0.5 mM IPTG 
concentration. The values for FL/OD600 show that the 10X looks to have the highest 
GFP expression, although it isn’t clear if the differences are statistically significant. A 
one-way ANOVA analysis was used to test if there is a significant difference between 
the different strength RBS constructs at each concentration of IPTG. The p values for 
all three IPTG concentrations were <0.00001, showing that there is a statistical 
significance between the constructs. Figure 4.12 illustrates the expression differences. 
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Figure 4.11 Time-course OD600, FL485-538 and FL485-538/OD600 growth curves using 
construct TU1 from Table 4.3 measured at IPTG concentration of 0.5 mM. 
E.coli cells were grown in LB broth at 37ºC with shaking at 225rpm in a 96 well plate,  
with a starting OD600 0.01 and letting the cells grow to stationary phase. OD600 
and FL485-538 was monitored using a plate reader SpectraMaxM5. Cells were 
supplemented with 0.5 mM IPTG to look at affect on GFP expression levels.  
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Figure 4.12 Histograms of the RBS+loc constructs at 0 mM, 0.5 mM and 1 mM IPTG 
concentration. 
The histograms show that the highest FL/OD600 value is for the 10X RBS construct, 
at all concentrations of IPTG tested. The results of a one-way ANOVA showed that 
there is statistical significance between the each of the RBS constructs 
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4.3.4 RBS + Cphy1178/STM2051 localisation sequence plate FACS 
analysis 
 
For the preliminary FACS analysis, the TU4 construct (Table 4.3) was used. The 
change to the constitutive promoter meant that an overall basal expression level was 
established, without the need for induction with IPTG. The constructs had the STOP 
terminator, were transformed into BL21 E. coli cells and were grown in M9 minimal 
medium. Figure 4.13 shows the results of the FACS sorting analysis, under the 
conditions specified in Materials and Methods. The histograms of Cphy1178 
constructs for both the plate reader assays and FACS analysis (Figures 4.12 and 4.13) 
show the highest FL/OD600 values and geometric mean values for the Cphy1178 10X 
RBS+loc construct. The geometric mean is used for FACS, as it useful to compare the 
single ‘figure of merit’ - in this case GFP fluorescence count- rather than when each 
item has multiple properties that have different numeric ranges. 
 
4.3.5 Summary and discussion 
 
These preliminary results cannot be directly compared as the growth medium differs 
between plate reader and FACS experiments (LB and M9 minimal medium 
respectively). For the STM2051 RBS+loc constructs, the mean increases with the 
strength of the designed RBSs. The geometric mean values for the STM2051 1000X 
are almost 6 times higher than for the Cphy1178 1000X constructs, although much 
more work is needed to conclusively prove a quantifiable difference between RBS+loc 
construct strength discussed in detail in Chapter 5. 
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Figure 4.13 Histograms of the geometric means from FACS sorting analysis for Cphy1178 and 















Different homologues of the common EutM protein show different charge states across 
the surface of the protein (Held et al., 2013; Pitts et al., 2012), with EutM having a 
strongly negatively charged pore (Takenoya et al., 2010) and the homologue CD1918 
from Clostridium difficile having a more even charge across the surface (Pitts et al., 
2012). This suggests that there is a difference in charge states across the surface of the 
protein, not only between EutM domains from different species, but also between the 
same species. 
Overexpression of EutM protein tends to lead to aberrant growth in cells. The aim of 
rationally expressing BMC shell proteins is to use them as scaffolding systems (Noël 
et al., 2016; Quin et al., 2017), although more needs to be known about EutM protein 
surface charge and pore before this would be possible. 
 
4.4.2 pET28a-GG-RFP plasmid for one-pot cloning of ORFs for 
overexpression 
 
The commonly used pET28a vector is useful for cloning as it contains the T7 promoter 
system, for in-frame protein production under IPTG control, as well as an inbuilt His6 
tag on the 3’ end of the multiple cloning site (MCS). However a problem with standard 
cloning is that it can be time consuming, as two separate enzymes are generally needed 
to insert the PCR product into the vector. By modifying the pET28a vector with the C- 
and D- defined overhangs, it is possible to quickly clone into a strong protein 




Figure 4.14 Plasmid map of the pET28a vector, engineered into a MoClo compatible protein 
expression vector 
The RFP fluorescent reporter is knocked out when a construct is successfully 
inserted between the C – and D- overhangs, so if plated onto LB agar supplemented 
with IPTG, it is possible to differentiate which colonies have cloned in the gene of 
interest.  
 
4.4.3 Construct expression and purification by ammonium sulfhate 
precipitation 
 
EutM constructs from Desulfotalea psychrophila, Psychromonas hadali, Salmonella 
enterica and Thauera linaloolentis were received from Maureen Quin in the Schmidt-
Dannert lab (University of Minnesota), and were cloned into the golden- gate pET28a 
plasmid, both with and without a stop codon, to generate untagged and His6-tagged 
constructs. All four of the constructs expressed well under standard over-expression 
conditions (growth to OD600 0.6, induction with 1 mM IPTG, 4 hours growth at  
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37 ºC in 1 litre cultures and so were subject to purification. Figures 4.15 and 4.16 show 
the anion exchange purification of the untagged D. psychrophilia (Dp) and P. hadalis 
(Ph) constructs. The majority of the protein was found in the flow-through fraction for 
both constructs, and formed a cloudy/iridescent lysate, which was found to be soluble 
protein, as centrifugation of the samples did not form a pellet. It was suggested by our 
collaborators that the EutM protein was forming sheet-like structures in solution, so it 
was decided to further purify the sample for further analysis by atomic force 
microscopy (AFM) as carboxysome shell proteins had been previously studied to great 
success by this method (Erbilgin et al., 2016). 
A second purification step of size-exclusion chromotagraphy did not give sufficient 
amounts of protein for downstream analysis by AFM, so purification by ammonium 
sulfate precipitation was introduced. Figure 4.17 shows that most of the Dp construct 
was recovered at 10% w/v and 20% w/v ammonium sulfate concentration; although 
there is discernible protein for the 30%, 50% and 80% fractions. Ph shows faint protein 
bands in the 10%, 20% and 30% fractions, however the majority of the protein was 
purified from the 50% and 80% fractions. 
 108 
 
Figure 4.15 Anion exchange purification of recombinant EutM from Desulfotalea 
psychrophila. 
Fraction FT corresponds to the flow-through. Fractions were eluted by a l inear 
gradient over 20 column volumes from 0–1 M NaCl as fractions from FT-60. Fractions 
from FT to 60 were analysed by 15% w/v SDS-PAGE, with the majority of the protein 






Figure 4.16 Anion exchange purification of recombinant EutM from Psychromonas hadalis 
Purification from a 12 ml Q-sepharose column Fraction FT corresponds to the flow-
through. Fractions were eluted by a l inear gradient over 20 column volumes from 0–
1 M NaCl as fractions from FT-71. Fractions from FT to 71 were analysed by 15% 
w/v SDS-PAGE, with the majority of  the protein (s ize denoted by red arrow, 10 kDa) 
in the flow-through fraction. 
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Figure 4.17 Ammonium sulfate precipitation of recombinant EutM from 
Desulfotalea psychrophila (Dp) and Psychromonas hadali (Ph). 
Flow-through fractions of Dp and Ph from anion exchange were subject to ammonium 
sulfate precipitation. Proteins were sequentially precipitated from 50 ml of crude 
extract by stepwise addition of solid ammonium sulfate with stirring at a certain 
degree of saturation. The pellet obtained after each centrifugation step was 
resuspended in max. 10 ml anion exchange buffer. Steps were repeated for 10, 20, 
30, 50 (top gel) and 80% (bottom gel) ammonium sulfate and fractions were analysed 
by 15% w/v SDS-PAGE. Size denoted by red arrow, 10 kDa.  
 
The second stage of purification did not produce a clear lysate, although centrifugation 
of the lysate suggested that the protein was still in solution as no pellet was formed. It 
was decided that thin-section electron microscopy (TEM), would be the next step to 
show the EutM proteins in vivo and to ascertain their structure inside the cell. 
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4.4.4 Thin-section electron microscopy of EutM shell proteins 
 
Although only the Dp and Ph EutM constructs were expressed and purified on a larger 
scale due to time constraints, the untagged and His6-tagged variants of EutM Dp, Ph 
and Stm and the untagged variant of Tl were subjected to TEM. It was not possible to 
produce the His6-tagged Tl construct in the timeframe of the project, so only the 
untagged version was available for TEM. The results of this experiment were 
interesting; the tagged and untagged versions of the constructs all showed normal E. 
coli cell growth in liquid culture; however, the morphology of the cells was highly 
distorted, with the cells elongated up to double their normal size of 1-2 µm (Figure 
4.18 (C) and Figure 4.20 (A). It appears that the E. coli cell is elongated due to its 
inability to separate into two daughter cells due to the sheets of EutM protein running 
through the centre of the cell and interfering with the correct formation of a competent 
division septum. At first glance there is little difference between the untagged and 
His6-tagged version of the EutM constructs, with both variants showing this distorted 
morphology across the four different protein species (Figures 4.18, 4.19, 4.20 and 
4.21). The transverse views of each construct (Figures 4.18 (B) and (D), Figure 
4.19(B) and (D), Figure 4.20 (B) and (C) and Figure 4.21 (B) and (C)), show a tight 
spiral-like arrangement of EutM protein spanning the entire diameter of the cell. In 
Figure 5.9, it appears that there is a slight difference in the diameter of the protein 
spiral, with the un-tagged Dp construct (Figure 4.18 (B)) appearing to be slightly 
smaller and more tightly curved than in the His6-tagged construct (Figure 4.18 (D)). 
However, it is difficult to prove the same effect between the other three species 
constructs (Ph, Stm and Tl). A reason for this could be that the His6 tag interferes with 
the EutM protein spiral, leading to a less-tightly packed protein conformation. 
 112 
 
Figure 4.18 Thin-section transmission electron micrograph images of overexpression of 
recombinant EutM protein from Desulfotalea psychrophila in E. coli cells 
Images taken with the Philips CM100 TEM at Newcastle University. A) Longitudinal 
view of E. coli showing overexpression of untagged EutM from D. psychrophila.  Cell 
shows distorted and elongated morphology, image taken at 46,000 x magnification. 
B) Transverse view of E. coli showing overexpression of untagged EutM from D. 
psychrophila. Cell shows spiral arrangement of EutM protein clusters, spanning the 
entire cell. Image taken at 46,000 x magni fication. C) Longitudinal and transverse 
views of multiple E. coli cells showing overexpression of His6 tagged EutM from D. 
psychrophila. Image taken at 13,500 x magnification. D) Longitudinal and transverse 
views of multiple E. coli cells showing overexpression of His6 tagged EutM from D. 
psychrophila. Image taken at 46,000 x magnification. Both tagged and untagged 
versions of the EutM protein seem to show similar morphology within the cell,  
however from the transverse views it  appears that the untagged proteins show a 
tighter spiral than the His6 tagged version. 
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Figure 4.19 Thin-section transmission electron micrograph images of overexpression of 
recombinant EutM protein from Psychromonas hadalis in E. coli cells 
Images taken with the Philips CM100 TEM at Newcastle University. A) Longitudinal 
view of E.coli showing overexpression of untagged EutM from P. hadalis.  Cell shows 
distorted and elongated morphology. Image taken at 34,000 x magnification. B) 
Transverse view of E. coli showing overexpression of untagged EutM from P. 
hadalis. Cell shows spiral  arrangement of  EutM protein clusters, spanning the entire 
cell. Image taken at 34,000 x magnification. C) Transverse views of multiple E. coli  
cells showing overexpression of His6 tagged EutM from P. hadalis, image taken at 
34,000 x magnification. D) Longitudinal and transverse views of multiple E. coli cells 
showing overexpression of His6 tagged EutM from P. hadalis. Image taken at 46,000 
x magnification. Both the longitudinal  and transverse views show overall  similar size 
and shape of protein structures for tagged and untagged EutM. 
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Figure 4.20 Thin-section transmission electron micrograph images of overexpression of 
recombinant EutM protein from Salmonella enterica in E. coli cells 
Images taken with the Philips CM100 TEM at Newcastle University. A) Longitudinal 
view of E. coli showing overexpression of untagged EutM from S. enterica. Cell  
shows distorted and elongated morphology. Image taken at 34,000 x magnification. 
B) Transverse view of E. coli showing overexpression of untagged EutM from S. 
enterica. Cell shows faint dots, relating to the overexpressed EutM protein. Image 
taken at 11,000 x magnification. C) Transverse views of multiple E. coli cells showing 
overexpression of His6 tagged EutM from S. enterica. Image taken at 34,000 x 
magnification. The EutM protein appears to be forming sheets, rather than spiral-
l ike arrangements. D) Longitudinal and transverse views of multiple E. coli cells 
showing overexpression of His6 tagged EutM from S. enterica. Image taken at 
11,000 x magnification. The comparison between tagged and untagged EutM is not 
as clear from these images, although from the longitudinal views in A) and C), the 
protein arrangement looks to be similar.  
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Figure 4.21 Thin-section transmission electron micrograph images of overexpression of 
recombinant EutM protein from Thauera  linaloolentis  in  E. coli cells 
Images taken with the Philips CM100 TEM at Newcastle University. A) Longitudinal 
and transverse views of E. coli showing overexpression of untagged EutM from T. 
l inaloolentis. Cells shows distorted and elongated morphology. Image taken at 
34,000 x magnification. B) and C) Transverse view of E. coli showing overexpression 
of untagged EutM from T. l inaloolentis. Both images show multiple, spiral-l ike 
arrangements of EutM proteins, averaging around 40 spirals/cell. Images both taken 
at 64,000 x magnification D) Longitudinal view of E. coli showing overexpression of 
untagged EutM from T. l inaloolentis. Image taken at 64,000 x magnification. The 
EutM protein structures are shown to run through the entire length of the cell. The 
His6 tagged version of the T. l inaloolentis EutM was unable to be cloned. 
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4.4.5 Summary and discussion 
 
It has been shown that the EutM protein has a concave and convex side, with the 
concave side holding the N- and C- terminal of the protein (Held et al., 2013); these 
constructs have been generated with a C-terminal His6 tag and so the tag is likely to 
also reside in the concave side of the protein. Different homologues of the EutM 
protein show different charge states across the surface (Held et al., 2013; Pitts et al., 
2012), with EutM having a strongly negatively charged pore (Takenoya et al., 2010) 
and the homologue CD1918 from Clostridium difficile having a more even charge 
across the surface (Pitts et al., 2012)This suggests that there is a difference in charge 
states across the surface of the protein even between the same protein from different 
species. Although the TEM images from the four different EutM examples shown here 
do not conclusively show that there is a difference between the protein packing, the 
fact that overexpression of the protein forms spirals in itself suggests that the concave 
and convex sides to the protein have differing charge states, and this could affect the 





5.1 Expression and purification of acylating aldehyde 
dehydrogenase enzymes 
 
The truncated versions of three putative aldehyde dehydrogenase enzymes from 
Clostridium phytofermentans were expressed as recombinant proteins in E. coli 
BL21(DE3) cells. The enzymes were purified in two stages, first by ion-exchange 
chromatography, over a 12 ml Q-sepharose column and further by size-exclusion 
chromatography, which yielded sufficient pure protein for further analysis and 
experiments. 
The enzymes were then used for further experiments to characterise them 
biochemically and structurally; including the aldehyde dehydrogenase assays and 
structure determination by X-ray crystallography. From the well-expressed 
Cphy1178_20 construct, two variants were proposed, C269A and H387A; these were 
cloned, expressed and purified. These variants were then tested for specific activity 
along with the wild-type protein and were also subject to further structural analysis. 
 
5.1.2 Activity of aldehyde dehydrogenase Cphy1178 against short chain 
fatty-aldehydes 
 
Cphy1178 was tested for activity against the C2-C6 short-chain fatty aldehydes; it 
displayed the highest turnover rate for propionaldehyde, confirming that this enzyme 
is a propionaldehyde dehydrogenase as inferred from the BMC encoded pathway in 
the C. phytofermentans fucose/rhamnose BMC locus. The active site variants C269A 
and H387 showed no activity against the range of aldehydes tested. Recent papers from 
(Zarzycki et al., 2017)and (Becher et al., 2018) confirm the catalytic mechanism 
proposed, with characterisation of a propionaldehyde dehydrogenase homologue from 
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Rhodopseudomonas palustris, that has the highest kcat/KM values against the 
propionaldehyde substrate. Substrate inhibition was also noted at higher aldehyde 
concentrations, which is consistent with a yeast aldehyde dehydrogenase enzyme and 
the data presented in this thesis. The reason suggested for this inhibition at higher 
concentrations is that a dead-end enzyme-NADH- aldehyde complex may be formed 
(Wang et al., 2009). 
 
5.1.3 Crystal structures of aldehyde dehydrogenase Cphy1178 with NAD+ 
and Co-enzyme A in the nucleotide binding domain 
 
The Cphy1178 aldehyde dehydrogenase was crystallised with the NAD+ cofactor in 
the cofactor-binding pocket; similarly the Cys269A variant was crystallised with Co- 
enzyme A in the same binding pocket although, in this complex the adenine ring lies 
in the opposite conformation. The proposed mechanism of action for this enzyme is 
that the H387 residue deprotonates the catalytic cysteine to allow nucleophilic attack 
on the substrate to form the tetrahedral acyl-enzyme intermediate. 
Following hydride transfer to the NAD+ cofactor, the NADH leaves the binding 
pocket, followed by entry of the CoA cofactor. The E357 residue is proposed to 
deprotonate the CoA, which then attacks the acyl-enzyme intermediate to form the 
thioester product and free enzyme. The extra proton on E357 is suggested to be 
transferred to water. However, the paper by Zarzycki et al. (2017), suggests a slightly 
different mechanism for the R. palustris homologue. They state that the acylated 
cysteine residue adopts a different rotamer conformation, which makes it inaccessible 
to the conserved glutamic acid residue. They propose that the H449 residue is involved 
in the deprotonation of CoA via two water molecules. 
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Before the publication of (Zarzycki et al., 2017), an E357A variant had been proposed 
to confirm that this residue is involved in the deprotonation of the CoA molecule. The 
crystal structure of this variant shows a CoA molecule in the expected conformation 
in the cofactor binding pocket. However, these were apo-crystals and were not exposed 
to CoA experimentally. A suggestion for this observation is that the CoA has become 
‘trapped’ in the binding pocket, because the proton had not been abstracted. The two-
models are not particularly mutually-exclusive in this regard and it is possible that both 
the water molecules and E357 residue have a part to play in the deprotonation of CoA. 
 
5.2 Building synthetic microcompartments 
 
The MoClo toolkit, developed by the Densmore laboratory (Iverson et al., 2015), 
contains a series of biological ‘parts’ for the E. coli chassis; which can be built into 
transcriptional units using type II restriction cloning. Although the toolkit is a great 
jumping off point for the rapid assembling of standardised transcriptional units, some 
useful features, such as C-terminal protein tags, are not included. Before any synthetic 
BMC constructs could be made, these tags were designed and added to the Toolkit 
terminators. Another useful feature developed was the modification of the pET28a 
cloning vector into a Golden-Gate compatible vector to facilitate protein expression-
construct generation. 
 
5.2.1 Bacterial microcompartment shell protein constructs 
 
Many efforts have been made to engineer bacterial microcompartment shells, 
including creating empty carboxysomes (Menon et al., 2008), overexpression of BMC 
shell proteins from a Pdu microcompartment (Parsons et al., 2008), formation of 
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nanotubes using a BMC-H protein (Noël et al., 2016) and engineering of BMC shell 
proteins to introduce a new function (Aussignargues et al., 2016). However, these tend 
to use classical cloning methods or completely synthetic DNA synthesis. These 
methods are costly and time consuming, particularly if large numbers of constructs 
need to be produced. 
To quickly generate large numbers of synthetic BMC shells to determine their basic 
assembly principles, the shell proteins from the C. phytofermentans fucose/rhamnose 
microcompartment and the Salmonella enterica Pdu microcompartments were cloned 
into the MoClo system, to look at how different amounts of the three shell protein 
domains affect microcompartment formation; and to see what effects, if any, the 
position of the shell proteins in a ‘locus’ has on BMC shell formation. 
 
5.2.2 Forward engineering of RBS + aldehyde dehydrogenase localisation 
sequences to study downstream protein expression 
 
A series of rationally-designed RBS + aldehyde dehydrogenase localisation sequence 
constructs were made and cloned into the MoClo Toolkit Level 0 plasmid. The RBSs 
were designed with different binding strengths, at a 1X, 10X, 100X and 1000X 
proportional log scale. The rationale for these constructs was to identify whether a 
fixed protein sequence downstream of the designed RBS would a) affect reporter 
protein expression levels and b) proportionally target the reporter protein to a native 
microcompartment. With a number of groups attempting this work with related 
microcompartment proteins, this work is of particular interest in the field (Fan et al., 
2010; Kinney et al., 2012; Quin et al., 2016). 
After the successful cloning of the RBS+loc constructs into the Toolkit, two different 
degron tags were added to the 5’ region of the MoClo terminators. Several constructs 
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were made, with either constitutive or controllable promoters, the 1X, 10X, 100X or 
1000X RBS+loc, and a GFP or Philov reporter. Constructs were made with and 
without the C-terminal degron tags. 
Although this work was largely preliminary, some initial plate reader and flow 
cytometry assays suggested that for the Cphy1178 constructs, the 10X RBS+loc gave 
the highest overall values for GFP fluorescence. The initial hypothesis was that the 
higher strength RBSs would give proportional GFP expression, however it may be the 
case that the sequence of the 10X RBS+loc construct is particularly amenable to 
ribosome binding in E. coli. It is important to observe that there are limitations with in 
silico construct design; bacterial transcription and translation can have many 
unidentified variables, which would mean that a rational design would not always 
work correctly in vivo. For this reason, the iterative nature of synthetic biology is 
useful – as constructs are quick and cheap to clone, many variables can be tested with 
relatively little effort. 
  
5.2.3 EutM shell proteins – expression and thin-section electron 
microscopy 
 
Different homologues of the EutM protein show different charge states across the 
surface of the protein (Held et al., 2013; Pitts et al., 2012), with EutM having a strongly 
negatively charged pore (Takenoya et al., 2010) and the homologue CD1918 from 
Clostridium difficile having a more even charge across the surface (Pitts et al., 2012). 
This suggests that there is a difference in charge states across the surface of the protein 
even between the same protein from different species. 
Although TEM images from the four different EutM examples shown do not 
conclusively show that there is a difference between the protein packing, the fact that 
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overexpression of the protein forms spirals in itself suggests that the concave and 
convex sides to the protein have differing charge states, and this could affect the 
packing of the protein within the spirals. A similar affect has been shown in 
(Choudhary et al., 2012; Heldt et al., 2009; Parsons et al., 2008) and also with the 
EutM CD1918 homolgue from Clostridium phytofermentans in (Pitts et al., 2012). In 
terms of BMC production, and the use of shell proteins as scaffolds to increase enzyme 
efficiency, it means that rational, well-informed design of shell protein structures is 
needed, with the ability to test large libraries of BMC proteins, which is possible with 
the MoClo system described here. 
 
5.3      Future work 
 
5.3.1 Propionaldehyde dehydrogenase structure and biochemistry 
 
To further elucidate the role of the E357 residue in the active site of the 
propionaldehyde dehydrogenase Cphy1178, the NAD+ turnover assay would be 
carried out with the E357A variant. Although this particular assay only follows the 
initial rate-limiting step of NAD+ to NADH turnover, it would be useful to see if the 
variant is inactive, along with the H387A and C269A. Soaking Cphy1178 E357A apo- 
crystals with both NAD+ and CoA would be beneficial, particularly to try and resolve 
the pantothenate group that has so far been elusive, or even to capture the acyl- enzyme 
intermediate. 
Another interesting Cphy1178 variant would be to the A235 residue. In non- acylating 
aldehyde dehydrogenases, this particular residue is a conserved glutamic acid. An 
A235E variant would possibly show the difference in mechanism between the 
acylating and non-acylating aldehyde dehdyrogenases. 
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5.3.2 Bacterial microcompartments as tools for synthetic biology 
 
Overall, bacterial microcompartments confer two main advantages to a bacterial cell; 
they sequester enzymes and substrates in the case of carboxysomes, increasing enzyme 
turnover and they protect the cell from toxic and volatile intermediate formed as part 
of sugar breakdown pathways in metabolosomes. These points could have 
implications in the production of biofuels (Fan et al., 2010; Lee et al., 2016; Petit et 
al., 2015; Zuroff and Curtis, 2012) or drug delivery systems (Jahn et al., 2013; Tsai 
and Yeates, 2011). Interesting directions this project could be taken in are 
• constructing and sequencing shell protein transcriptional units on a large scale 
to look at chimeric and homologous bacterial microcompartment shells, with a view 
to rationally designing shells for the targeting of specified enzyme pathways 
• refining the experimental parameters of the RBS + localisation sequence 
constructs, to accurately quantify reporter-gene targeting to native microcompartment 
shells 
• to crystallise the EutM homologues described in this study, to get a more 
accurate view of the different charge states across the protein’s surface and how this 
might be used to design novel protein scaffolding systems 
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6 Materials and Methods 
 
All chemicals used in this work were purchased from Sigma-Aldrich unless otherwise 
stated. Plasmid pET-28a(+) was purchased from Novagen. MoClo toolkit was 
purchased from Addgene (Iverson et al., 2015). 
 
6.1      Aldehyde dehydrogenase enzyme cloning 
 
The full-length wild-type Cphy1178, Cphy1428 and Cphy2642 were first cloned from 
the Lachnoclostridium phytofermentans ISDg (Clostridium phytofermentans ISDg). 
Various constructs including point mutations and truncated constructs were prepared 
by standard cloning methods as described below. 
 
6.1.1 Full-length and truncated protein cloning 
 
Primers to generate full-length Cphy1178 residues (1-462) were designed between the 
NcoI and XhoI restriction sites to clone into the pET-28a vector as shown in Table 
6.1. The truncated version of Cphy1178 (residues 20-462) was designed to cover the 
full-length construct, excluding the signal sequence (1-19) and to include restriction 
enzyme site to clone into the pET-28a vector (Novagen). 
To generate each construct, DNA was amplified by PCR in 50 µl reactions typically 
containing: either 10 ng of genomic template DNA or 1 ng plasmid template DNA; 
0.3 µM of both the forward and reverse primer, 0.02 U/µl KOD Hot Start DNA 
polymerase; 1.5 mM MgSO4; and 0.2 mM (each) of dNTPs in 1 X buffer for KOD 
Hot Start DNA polymerase. PCR programme was: 95 ºC for 2 min; followed by 30 
cycles of 95 ºC for 30 s, annealing temp for 10 s, 70 ºC for 30 s; and a final extension 
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of 70ºC for 10 min. Annealing temperatures varied between reactions, always being 
within 5ºC of the melting temperatures of each primer. 
The PCR reaction was visualized on a 0.8 % w/v agarose gel and PCR product was 
purified either by gel extraction or PCR clean-up using the QIAGEN PCR purification 
or gel extraction kits, following the manufacturer’s protocol. Amplified DNA and 
pET-28a vector were digested with the relevant restriction enzymes following the 
manufacturers instructions in a typical reaction volume of 20 µl. Digested vector and 
the digested amplified gene were purified using the QIAGEN PCR purification kit as 
above and ligated with NEB T4 DNA ligase as per manufacturers instructions. 5 µl 
ligated plasmid was transformed into 50 µl One Shot TOP10 Chemically Competent 
E. coli (ThermoFisher) with 45 s heat-shock at 42 ºC with recovery in 200 µl LB with 
incubation at 37 ºC for 40 min. 50 µl of transformed cells were plated onto LB agar 
supplemented with 50 µg/ml kanamycin and incubated overnight at 37 ºC. Single 
colonies were used to inoculate 5 ml of LB supplemented with 50 µg/ml kanamycin 
and were cultured overnight at 37 ºC, shaking at 250 rpm. The plasmid was extracted 
from overnight cultures using the QIAGEN miniprep kit according to manufacturer’s 
instructions, varying only in DNA elution volume (35 µl). The gene of interest was 
identified by a Sanger sequencing reaction, carried out by Edinburgh Genomics and 
using the T7 promoter and T7 terminator primers (Table 6.1). 
  
 126 
Construct Forward primer Reverse primer Restriction 
sites 
Tag 
Cphy1178(His) CTCCCATGGGCACAGTGAATGAACAATTG GGCCTCGAGTCGGATACACAAACTATC NcoI/XhoI C-His 
Cphy1178(20-
462) 
CTCCCATGGGCCAATTGACACAAACAAAT GGCCTCGAGTTATCGGATACACAAACT NcoI/XhoI n/a 
Cphy1428(His) GGCCATATGGAAAACTTTGATTTTGAT GGCCTCGAGCTACTGACCTTTCATGGC NdeI/XhoI N-His 
Cphy1428(1-448) GCGCCATGGGCTTTGATTTTGATCTGCGT GGCCTCGAGTTATTTCAGGCCAAAGGCAAC NcoI/XhoI n/a 
Cphy2642(His) CTCCCATGGAGTTACAAGAGAAAGAT GGCCTCGAGTATTAGTTGTTTCATAAT NcoI/XhoI C-His 
Cphy2642(1-452) GCGCATATGGAACTGCAAGAAAAAGATCTG GCGCTCGAGTTATTCTTTCACGCCAAAGGC NdeI/XhoI N-His 
Cphy1178(20-
462) C269A 
ATAATCTTCCAGCTATTGCAGAAAAAG CTTTTTCTGCAATAGCTGGAAGATTAT n/a n/a 
Cphy1178(20-
462) H387A 
ATGGTAATCGAGCTTCCGCACATAT ATATGTGCGGAAGCTCGATTACCAT n/a n/a 
Cphy1178(20-
462) E357A 
CCTTTGATTTCTGAAGCGTTAATGATGCCGATTC GAATCGGCATCATTAACGCTTCAGAAATCAAAGG n/a n/a 
T7 sequencing 
primers 
TAATACGACTCACTATAGGG GCTAGTTATTGCTCAGCGG n/a n/a 
Table 6.1 Primers used for the aldehyde dehydrogenase cloning 
Primer sequences for constructs used in this work. All primers are l isted 5’ to 3’, from left to right. Introduced restriction sites are shown 
underl ined; regions complimentary to genomic DNA shown in bold; sequence mismatches in mutagenic primers are shown in red.  
All primers are listed 5’ to 3’, from left to right 
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6.1.2 Site-directed mutagenesis of Cphy1178(20-462) active site residues 
 
To generate both full-length and truncated mutants Cphy1178(C269A), 
Cphy1178(H387A) and Cphy1178(E357A), mutagenesis primers were designed using 
the online programme PrimerX (Table 6.1). The PCR reaction was set up in 50 µl of 
1 X PfuUltra buffer and contained: 2.5 pmol/µl each of forward and reverse primer; 
40 mM dNTP mix (10 mM each); 2 ng/µl plasmid template (either Cphy1178 or 
Cphy1178(20-462)) and 2 U/µl PfuUltra Hotstart DNA polymerase. The PCR programme 
was: 95 ºC for 5 min; followed by 18 cycles of 95 ºC for 50 s, 60 ºC for 50 s, 68 ºC for 
2.5 min; and a final extension of 68 ºC for 7 min. After PCR, 20 U/µl of the enzyme 
DpnI was added to the reaction mixture and then incubated at 37 ºC for 60 min. 1 µl 
of plasmid was transformed in E. coli, cultured and the DNA was extracted as 
described above. The sequence of the mutated gene of interest was identified by a 
Sanger sequencing reaction, carried out by Edinburgh Genomics using the T7 
promoter and T7 terminator primers (Table 6.1) 
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6.2      Aldehyde dehydrogenase enzyme expression, purification and 
activity assays 
 
6.2.1 Aldehyde dehydrogenase expression 
 
Single colonies of E. coli BL21(DE3) cells were transformed with protein expression 
plasmid, and transferred into 10 ml LB medium supplemented with appropriate 
antibiotic, such as 50 ng/µl kanamycin for pET-28a(+). Inoculated cultures were 
incubated overnight at 37°C with shaking at 200 rpm. 1 litre of LB medium was spiked 
with the 10 ml overnight culture and additional antibiotic and incubated at 37°C with 
shaking at 200 rpm. Recombinant protein expression was induced at OD600 = 0.6 by 
the addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and further 
incubated at 37ºC for four hours. Cells were pelleted by centrifugation at 4000 x g for 
30 min at 4°C, and resuspended in 10 times v/w of PBS to wash cells before a second 
centrifugation at 4000 x g for 15 mins. 
 
6.2.2 Aldehyde dehydrogenase purification 
 
Untagged C. phytofermentans BMC shell proteins, and the BMC associated aldehyde 
dehydrogenase enzymes (Cphy_1178, Cphy_1428 and Cphy_2642), were purified as 
follows. Cells were resuspended in 10 times v/w of buffer QA (50 mM Tris.HCl pH 
8.0) and subjected to lysis by ultrasonication on ice (15 secs on, 15 secs off repeated 
for 8 cycles) The lysate was clarified by centrifugation (35,000 x g, 30 min) and the 
supernatant was filtered using a 0.45 µm syringe filter (Millipore). The filtered 
supernatant was loaded onto a 12 ml Q-sepharose column (GE Healthcare) 
equilibrated with buffer QA. Unbound sample was washed off with 10 column 
volumes of buffer QA and protein was eluted with a linear gradient of 0–100% buffer 
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QB (50 mM Tris.HCl pH 8.0, 1 M NaCl) over 20 column volumes. Peak fractions 
were analysed by 15% SDS-PAGE and fractions containing the protein of interest 
were pooled and concentrated using a 10 kDa MWCO centrifugal concentrator 
(Sartorius). Concentrated samples were subjected to size exclusion chromatography 
using a Superdex S200 HR16/600 column (GE Healthcare) equilibrated with Size 
Exclusion Chromatography buffer (50mM Tris.HCl pH8.0, 150mM NaCl). Protein 
fractions were assessed by 15% SDS-PAGE with molecular weight of fractions 
estimated with a broad range protein ladder (Fermentas). 
 
6.2.3 Aldehyde dehydrogenase activity assays 
 
Standard aldehyde dehydrogenase assays were performed with the following 
components: 100 mM Tris.HCl pH 8.0, 100 mM KCl, 0.6 mM β-NAD, 10 mM Beta-
mercaptoethanol, and various concentrations of Cphy_1178, Cphy_1428 or 
Cphy_2642 and various aldehyde substrates. Aldehyde substrates were made up to 
either 10 mM or 100 mM stock solutions with H2O, to minimise the aldehyde amount 
needed for each reaction. NAD+ was the final component added to the reaction, to 
ensure the shortest time between assay set-up and initial reading. The production of 
NADH was monitored by measuring change in A340 as a function of time, using an 
absorption co-efficient of 6.22 mM−1 cm−1 and a pathlength of 0.2 cm. Initial 
enzymatic activity tests were carried out using a benchtop UV/Vis spectrophotometer 
V-730 UV/VIS spectrophotometer (JASCO Inc.) (pathlength 1 cm), with 1 ml reaction 
volume, to test whether purified proteins were active. 
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For purified proteins with activity from initial exploratory experiments, assays were 
carried out to determine their kinetic parameters using a 96-well micro-titre plate 
reader (SpectraMax M5 (Molecular Devices)) with each well containing 300 µl of 
reaction buffer. For the acetaldehyde assay, Cphy_1178 was used at 100 nM final 
concentration, with A340 measured every 7 s for 182 s and the assay was carried out 
in 5 replicates. The assay blank used standard assay components without protein. 
Initial rates from linear regression for NADH produced for different substrate 
concentrations were obtained from data analysis. These initial rates produced a curve 
fitted with non-linear regression applying the Michaelis-Menten equation using Prism 
6 software (Graphpad). The nonlinear regression model associated with the Michaelis-
Menten equation is as follows: 
! = C(Vmax)/ (C + Km) + " 
where ε represents normally distributed errors, with zero mean and constant variance 
#2. It provides confidence intervals, estimates, and statistical hypothesis tests based 
on this assumption. 
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6.3      Crystallisation/Optimisation 
 
6.3.1 Protein crystallisation screening and optimisation 
 
Proteins were screened for crystallisation against the following commercial 
crystallisation kits: JCSG+, Structure Screen, and MIDAS from Molecular 
Dimensions. An Art Robbins Gryphon nanolitre pipetting robot was used to dispense 
65 µl of each crystallisation screen from a master screen kit into a MRC 96-well 
crystallisation plate. 0.1 µl reservoir solution was pipetted into each well, followed by 
0.2 µl and 0.1 µl protein dispensed into the top and bottom wells by the nanodispenser. 
The sitting- drop vapour-diffusion crystallisation plate was sealed with the X-Seal 
Manual Adhesive Sealer XCS-384 (FluidX). 
Purified Cphy1178(20-462) and the C269A, H387A and E357A variants were 
concentrated to between 8-12 mg/ml in 30 mM NaCl, 50 mM Tris.HCl pH8.0 and 
crystallised by sitting drop vapour diffusion in drops of 2 µl protein plus 2 µl 
crystallization solution, over 1 ml of crystallization solution after finding appropriate 
conditions from JCSG+ screen. Crystal trays were incubated at 18 ºC for between one 
and three weeks, and crystal formation was monitored using a Leica DFC450 C digital 
microscope at 10 X resolution. 
 
6.3.2 Crystal soaking and mounting 
 
Crystals were obtained in 0.1 M sodium acetate pH4.7, 1.8 M ammonium sulfate and 
grew as bi-pyramids of 50-100 µm in size. Crystals were harvested from the well using 
a LithLoop (Molecular Dimensions), transferred briefly to a saturated ammonium 
sulfate solution and then paratone oil (Molecular Dimensions). Excess oil was wicked 
off and the cryo-protected crystals were flash-cooled in liquid nitrogen. Crystals of 
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Cphy1178(20-462) with NAD+ and CoA ligands were obtained by soaking harvested 
crystals in a solution of 0.1 M sodium acetate pH4.7, 1.8 M ammonium sulfate, 
supplemented with 10 mM ligand and cryo-protected as described above. 
 
6.3.3 X-ray diffraction data collection and processing 
 
All crystallographic datasets were collected on beamlines I02 and I04 at Diamond 
Light Source (Didcot, UK) at 100 K and using ADSC CCD, or Pilatus 6 M detectors. 
Diffraction data were integrated and scaled using XDS (Kabsch, 2010) and merged 
with Aimless (Evans and Murshudov, 2013). The crystallographic point group and 
space group were determined by Pointless and symmetry related reflections were 
merged with Aimless (Evans and Murshudov, 2013). The resolution cut-off used for 
structure determination and refinement was determined based on the completeness 
(>95%), I/sigI (>1.5) and CC1/2 (>0.5) criterion of Karplus and Diederichs (Karplus 
and Diederichs, 2012). 
 
6.3.4 Crystallographic model building and refinement 
 
The structure of Cphy1178_20 was determined by molecular replacement using the 
PDD homologue (PDB ID: 3K9D) as the search model. A single solution was found 
by molecular replacement using Phaser MR (McCoy et al., 2007). The initial model 
was rebuilt using Phenix.autobuild (Terwilliger et al., 2008) followed by cycles of 
refinement with Phenix.refine (Adams et al., 2010), with manual rebuilding and model 
inspection in Coot (Emsley et al., 2010). Each refinement cycle in Phenix.refine 
included ten macrocycles of bulk solvent correction, anisotropic scaling, coordinate 
refinement, individual B-factors and occupancy refinement. The refinement target 
 133 
weights included scale factor for X-ray/stereochemistry weight (wxc_scale) as 0.5; for 
Xray/ADP weight (wxu_scale) as 1.0; stereochemistry weight scale (wc) as 1.0; ADP 
weight scale (wu) as 1.0. The refinement program was repeated for several cycles until 
the Rwork, Rfree and stereo chemical restraints achieved convergence. In the final 
stage of the refinement, water molecules and hydrogens were added to the protein 
model automatically in Phenix and further inspected in Coot manually. The final 
model was also refined with torsional NCS restraints (2.5° for restraint sigma and 15° 
for restraint limit). The crystal structures of Cphy1178(20-462) C269A, H387A and 




6.4      Cidar MoClo cloning 
 
6.4.1 Insertion of shell protein constructs into Level 0 vector 
 
The CIDAR MoClo Parts Kit was a gift from Douglas Densmore (Addgene kit # 
1000000059). All Level 0 plasmids have an ampicillin resistance gene, and cloning 
into any Level 0 plasmid was carried out with the BpiI type II restriction enzyme, and 
T4 DNA ligase, with quantities of each specified below. 
Shell protein constructs (Table 6.2) were designed with a 5’ C (AATG) overhang and 
a 3’ D (ACCT) overhang to be inserted into the MoClo toolkit system. The Cphy_1182 
construct had an internal BpiI site, so this was mutated via site-directed mutagenesis 
as in section 6.1.2 prior to Level 0 cloning. Genes were amplified by PCR from 
plasmid containing the gene of interest (supplied by Dr Jon Marles-Wright) and 
purified as in section 6.1.1, followed by a one-tube digestion/ligation reaction. 
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Construct Forward primer Reverse primer 5’ Fusion site 
3’ Fusion 
site 
Cphy_1176 GGCGAAGACATAatgacaaccgaagataaacttcgcattg GGCGAAGACATACCTggtacgtgttatgtcacat AATG ACCT 
Cphy_1180 GGCGAAGACATAatgggtttagcagttggattttta GGCGAAGACATACCTattcttatcaaagccgcttaagtg AATG ACCT 
Cphy_1181 GGCGAAGACATAatgggaaaatcgttaggctttatt GGCGAAGACATACCTcatttcttcgttttgtggctt AATG ACCT 
Cphy_1182 GGCGAAGACATAatggatgataaattagat GCCGAAGACATACCTtttaattcctggtaaaat AATG ACCT 
Cphy_1184 GGCGAAGACATAatgttaatcggcaaagtaa GGCGAAGACATACCTctccagtcctgttgcatc AATG ACCT 
Cphy_1186 GGCGAAGACATAatgagtaaagcaattgga GGCGAAGACATACCTcatcaacttattgcgtaa AATG ACCT 
STM2038 GGCGAAGACATAatgcaacaagaagcactagga GGCGAAGACATACCTttggctaattcccttcgg AATG ACCT 
STM2039 GGCGAAGACATAatgagcagcaatgagctg GGCGAAGACATACCTgatgtaggacggacgatc AATG ACCT 
STM2045 GGCGAAGACATAatgaataacgcactggga GGCGAAGACATACCTggctgatttcggtaaaat AATG ACCT 
STM2046 GGCGAAGACATAatgaagcaatcactggga GGCGAAGACATACCTcgcttcacctcgcttgcc AATG ACCT 
STM2049 GGCGAAGACATAatgcatctggcacgagtc GGCGAAGACATACCTacacgaaagcgtatctac AATG ACCT 
STM2054 GGCGAAGACATAatgtctcaggctatagga GGCGAAGACATACCTcccctccaccatctgtcg AATG ACCT 
STM2055 GGCGAAGACATAatggaaagacaaccgaca GGCGAAGACATACCTcgtccgggtgatcgagca AATG ACCT 
Cphy1182_mut GTGCAGCTAGCGCTGGGAGACTTGGTGAGTTAG CTAACTCACCAAGTCTCCCAGCGCTAGCTGCAC n/a n/a 
Table 6.2 Primers used for shell protein to Level 0 cloning and 
Primer sequences for constructs used in this work. All primers are listed 5’ to 3’, with overhangs highlighted in red. All primers are listed 
5’ to 3’, from left to right. Cphy_1182 mutated region is highlighted in blue 
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The reaction components and digestion/ligation parameters are shown in Tables 6.3 
and 6.4 respectively. 5 µl ligated plasmid was transformed into 50 µl One Shot TOP10 
Chemically Competent E. coli (ThermoFisher) with 45 s heat-shock at 42 ºC with 
recovery in 200 µl LB with incubation at 37 °C for 40 min 
 
Component Amount 
Shell protein part 10 fmol 
NEB Ligase buffer 1 X 
T4 DNA ligase (NEB) 20 U/reaction 
BsaI (NEB) 10 U/reaction 
Total reaction volume 20 µl 
Table 6.3 Level 0 Golden-Gate cloning reaction components and volumes 
 
Step number Temperature (ºC) Time (mins) 
1 37 20 
2 37 1.5 
3 16 3 
Cycle Step 2 and 3 x 7 
4 50 5 
5 80 10 
Table 6.4 Level 0 Golden-Gate cloning digestion and ligation parameters 
 
 
Transformed cells were plated on to X-gal plates (2.5 ml of 20 mg/ml stock solution 
of X-gal (200 mg X-gal, 10 ml DMSO), 1 mM IPTG, 50 µg/ml ampicillin) and 
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screened for white colonies. Single colonies were incubated in 10 ml LB supplemented 
with appropriate antibiotic for plasmid propagation. Plasmids were purified from the 
cells using the Qiagen Miniprep kit based on the manufacturer instructions. Gene 
insertion into the Level 0 plasmid was confirmed by Sanger sequencing of the resulting 
plasmid (Edinburgh Genomics). 
 
6.4.2 Insertion of terminator tags into MoClo toolkit 
 
The following tags were cloned into empty Level 0 DE, DF, DG and DH plasmids: 
Flag tag, HA tag, Strep tag and His6 tag. PCR primer sequences are shown in Table 
6.5. 










Table 6.5 Forward and reverse primers for terminator tag cloning 
B0015_ refers to the terminator gene name in the MoClo toolkit, DE, DF, DG and 
DH are the MoClo specified overhangs.  
PCR products were cloned using the MoClo Toolkit terminator, B0015, as a plasmid 
template (described in section 6.1.2). PCR products were subsequently purified and 
cloned into the appropriate Level 0 vector as described above. 
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6.5      RBS + localisation sequence design and cloning 
 
6.5.1 RBS + localisation sequence design 
 
Forward engineered RBSs were designed using the RBS calculator software from the 
Salis lab (Espah Borujeni et al., 2014; Salis et al., 2009), using the residues 1-18 in the 
STM2051 construct and 1-19 in the Cphy1178 construct. The pre-sequence was set as 
the MoClo B’ overhang (TACT), and the protein coding sequence was set as the first 
18 and 19 aa residues of STM2051 and Cphy1178 respectively. Proportional scales 
were set at 1X, 10X, 100X and 1000X strength for both constructs. 
 
6.5.2 RBS+localisation sequence cloning 
 
Forward and reverse primers for each construct were re-suspended in nuclease-free 
water to a concentration of 100 µM, and added together in NEB fast-digest buffer in 
equimolar amounts. The primer mix was placed in a heat block at 95 ºC for 5 minutes, 
with subsequent cooling at room temperature. Resulting annealed primers were then 
used as the component parts and cloned into the Level 0 vector, as shown in section 
6.1.2. 
Multiple Level 1 transcriptional units were generated using a mix of toolkit parts and 
lab-designed RBS+loc constructs and engineered terminators as shown in Table 6.7. 
Sheet showing each toolkit part relative to the kit number is shown in the Appendix. 
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Construct Forward primer Reverse primer 
S 1X …AAAATAAGAACAGAACCATTCAGCCCCAGGGatgaatacttctgaactcgaaaccctgattcgcaccattcttagcgagcaatta 
...taattgctcgctaagaatggtgcgaatcagggtttcgagttcagaagtattca 
tCCCTGGGGCTGAATGGTTCTGTTCTTATTTT 
S 10X …GAACTCGCGCCGCTCAACGCGAGTTCAAGTCAGatgaatacttctgaactcgaaaccctgattcgcaccattcttagcgagcaatta 
…taattgctcgctaagaatggtgcgaatcagggtttcgagttcagaagtattcat 
CTGACTTGAACTCGCGTTGAGCGGCGCGAGTTC 
























Table 6.6 Forward and reverse PCR primers for RBS + localisation sequence constructs 
The protein coding sequence is shown in lowercase letters and the 5’ and 3’ overhangs with junk DNA are shown in uppercase letters.  
The 3 red dots refer to sequence GGCGAAGACATTACT and the three blue dots refer to sequence GGCGAAGACATCATT.   S is STM2051 
and C is Cphy1178
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Component Amount 
Shell protein part 10 fmol 
NEB Ligase buffer 1 X 
T4 DNA ligase (NEB) 20 U/reaction 
BsaI (NEB) 10 U/reaction 
Total reaction volume 20 µl 





Step number Temperature (ºC) Time (mins) 
1 37 1.5 
2 16 3 
Cycle Step 1 and 2 x 15 
3 50 5 
3 80 10 
Table 6.8 Level 1 Golden-Gate cloning digestion and ligation parameters 
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TU Promoter_AB RBS+loc_BC Reporter_CD Terminator Level 1 plasmid_AE 
1 R0010 All E0040m STOP DVK_AE 
2 R0010 All E0040m STOP DVK_AE 
3 J23100 All E0040m STOP DVK_AE 
4 J23100 All E0040m STOP DVK_AE 
5 J23100 All E0040m LAA_Degron tag DVK_AE 
6 J23100 All E0040m LVA_Degron tag DVK_AE 
7 J23100 All Philov STOP DVK_AE 
8 J23100 All E0040m LVA_Degron tag DVK_AE 
9 J23100 All E0040m LVA_Degron tag DVK_AE 
Table 6.9 Level 1 RBS+loc transcriptional unit constructs 
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6.5.3 RBS + localisation sequence plate reader assays 
 
Fluorescence levels of gene expression were assayed by fluorometry at cell population 
level and by flow cytometry at single-cell level. Cells grown in 96-well plates were 
monitored and assayed using a BMG POLARstar fluorometer for repeated absorbance 
(OD600) and fluorescence (485 nm for excitation, 520 ± 10 nm for emission, Gain = 
1,000) readings (20 min per cycle). 
 
6.5.4 RBS+ localisation sequence flow cytometry 
 
For each variant, cell cultures were diluted 1:4000 in 200 µL of phosphate buffered 
saline in 96-well plates, and 5000 events were collected on a Millipore Guava 
easyCyte 5HT flow cytometer. Gates were set around the cell population using the 
forward and side scatter channels, and average fluorescence values were calculated 
using the geometric mean. 
6.6     EutM cloning, protein expression and purification and thin- 
section electron microscopy 
 
6.6.1 Cloning EutM into Golden-Gate modified pET28a 
 
Cloning was carried out as shown in earlier sections, replacing the Level 0 CD plasmid 
with the pET28a-GG-RFP plasmid Level 1 plasmid. BsaI and T4 DNA ligase were 
used consistently for the Golden-Gate cloning reactions, the quantities shown in 
section 6.1.4 are the same throughout the project. 
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EutM 































Table 6.11 Primers for EutM constructs to be cloned into the amended Golden-Gate pET28a vector 
C’ overhangs are highlighted in red and D’ overhangs are highlighted in blue 
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6.6.2 Ammonium sulfate precipitation of D. psychrophila and P. hadalis 
EutM proteins 
 
Dp and Ph proteins were purified by anion exchange, as described in section 6.1.2. 
The supernatant was centrifuged at 5000 x g for 15 minutes at room temperature. 
Proteins were sequentially precipitated from 50 ml of crude extract by stepwise 
addition of solid ammonium sulfate with stirring at a certain degree of saturation, and 
then centrifuged again at 5000 x g at 4°C for 15 minutes. The pellet obtained after each 
centrifugation was resuspended in max. 10 ml anion exchange buffer. Steps above 
were repeated for 20, 30, 50 and 80% ammonium sulfate. 
Precipitated fractions were analyzed for its protein purity by 12% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
6.6.3 Thin-section electron microscopy of EutM constructs 
 
E. coli Top10 cells transformed with the plasmids for untagged and His6-tagged Dp, 
Ph, Stm and Tl constructs were grown to mid-log phase in Luria-Bertani media 
supplemented with 50 µg/ml kanamycin. 1 ml of these cells were fixed in 2.5% (v/v) 
glutaraldehyde, 50 mM sodium cacodylate pH 7.0 for 30 mins at room temperature. 
Cells were subsequently immobilized in 2% (w/v) water-agar and post-fixed in 1.5% 
(w/v) osmium tetroxide in 50 mM sodium cacodylate pH 7.0 for 1 hour at 4°C 
followed by dehydration in an ethanol series. The final 70% dehydration step was 
supplemented with 1% (w/v) uranyl acetate and was performed overnight at 21°C. 100 
nm sections were post-stained with 2% (w/v) uranyl acetate and analysed using a 





7.1 Calibration of HiLoad 16/600 Superdex 200pg Size Exclusion 
Chromatography column 
 
Size Exclusion Chromatography provides a means to estimate the molecular weight or 
size (Stokes radius) of proteins under certain buffer and temperature conditions. The 
molecular weight of unknown proteins can be determined by comparing the elution 
volume related parameter Kav to those calculate from known calibration standards run 
on the same column. Here a calibration curve for a HiLoad 16/600 Superdex 200pg 
column was prepared by running LMW/HMW calibration kits (GE Healthcare) to 
measure the elution volume (Ve) of each protein standard (Figure 1 A). The void 
volume (Vo) of S200 column was estimated based on the retention volume of blue 
dextran 2000. The Kav value was derived based on the equation:  
Kav = (Ve – Vo) / (Vt – Vo) 
Where Vt equals to the total bed volume of particular column. Kav was then plotted 
against the logarithm of molecular weight of protein standards (Figure 1 B) It should 
be borne in mind that protein shape also affects the Kav- based molecular weight 




Figure 1 Chromatographic separation and calibration curve for HiLoad 16/600 Superdex 200 pg 
column. 
(A) Chromatogram of HiLoad 16/600 Superdex 200 pg Size Exclusion 
Chromatography column calibration using blue dextran 2000 (B, blue solid curve),  
MixA (red dashed curve) and MixB (black dashed curve) in which blue dextran 
determines the void volume. MixA contains ferritin (F, 440 kDa), conalbumin (C, 75 
kDa), carbonic anhydrase (CA, 29 kDa) and ribonuclease A (R, 13.7 kDa). MixB 
consists of ovalbumin (O, 44 kDa), aprotinin (Apr, 6.5 kDa), ribonuclease A and 
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